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I. Preface 
 
This thesis was performed at the Inflammation Research Unit, Department of Internal 
Medicine, University Hospital of Zurich, Zurich, Switzerland. It is an account of the 
results of projects supported by Fonds zur Föderung des Akademischen 
Nachwuchses (FAN) of the University of Zurich, and partially project No. 31-120658 
of the Swiss National Science Foundation. 
 
The aim of this work was to study the hemoglobin induced catabolism in human 
macrophages and the resulting global and characteristic impact on the transcriptome 
and proteome in order to define a novel phenotype of hemoglobin clearing 
macrophages in wounded tissues and inflammation. 
 
The data is presented in form of manuscripts submitted or prepared for publication 
(chapters 2, 3, and 4). In chapter 1, an introduction in the biology of macrophages 
with emphasis on their role in hemoglobin clearance and catabolism, and an outline 
of the thesis are given.  
 
An overall picture of the findings presented in this work and the conclusions drawn 
are given in chapter 5. 
 
Parts of the work have been conducted in cooperation with the Functional Genomics 
Center Zurich, University of Zurich and ETH Zurich. 
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II. Abbreviations  
ACN   Acetonitrile 
ARE   Antioxidant response element 
CID   Collision-induced dissociation 
CIITA   Class II transactivator 
DMEM  Dulbecco‟s modified eagle medium 
FCS   Fetal calf serum 
FDR   False discovery rate 
FTH   Ferritin heavy chain 
FTL   Ferritin light chain 
GSH   Reduced glutathione  
Hb   Hemoglobin 
HCD   Higher-energy collisional dissociation 
HLA   Human leukocyte antigen 
HO-1   Heme oxygenase 1 
Hp   Haptoglobin 
iTRAQ  Isobaric tag for relative and absolute quantitation 
LPS   Lipopolysaccharide 
LTQ   Linear trap quadrupole 
MALDI  Matrix assisted laser desorption ionisation 
MS   Mass spectrometry 
Nano-LC  Nano liquid chromatography 
NF-κB   Nuclear factor 'kappa-light-chain-enhancer' of activated B-cells 
Nrf-2   Nuclear Factor E2-related factor 2 
PAI-2   Plasminogen activator inhibitor type 2 
ROS   Reactive oxygen species 
SOD   Superoxide dismutase 
SPR   Surface plasmon resonance 
SRCR   Scavenger receptor cysteine rich 
TCA   Trichloroacetic acid 
TFA   Trifluoroacetic acid 
TOF   Time-of-flight
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III. Zusammenfassung 
Das sauerstofftransportierende Protein Hämoglobin (Hb) ist anfällig für oxidative 
Schädigungen aufgrund seiner reaktiven Hämgruppe. Allein die Abschirmung durch 
die Erythrozytenmembran ermöglicht, dass Hämoglobin den Körper ausreichend mit 
Sauerstoff versorgen kann. 
Zellfreies Hb tritt in verschiedenen Mengen während der Zerstörung von 
Erythrozyten, Gewebeverletzungen, Sichelzellanämie und Malaria auf. Das 
Freiwerden von sehr grossen Hämoglobinmengen in der Zirkulation hat 
verschiedenste klinische Konsequenzen, wobei man zwischen Kurz -und 
Langzeitkonsequenzen unterscheidet. Kurzzeitkonsequenzen sind unter anderem die 
oxidative Denaturierung von Hämoglobin, das verminderte Vorhandensein von 
vasoaktivem NO, Proteinschädigungen und Nierenversagen. Auf längere Sicht 
können Entzündungen, Bluthochdruck oder intraplaque Blutungen in 
fortgeschrittenen atherosklerotischen Läsionen auftreten. Haptoglobin (Hp) ist der 
primäre Hämoglobinfänger, der sofort und effektiv die verschiedenen toxischen 
Effekte von Hämoglobin durch die Bildung von stabilen Hb-Hp Komplexen minimiert 
und die Beseitigung der Komplexe durch den Makrophagen Rezeptor CD163 
einleitet.  
Aufgrund der wichtigen Funktion von CD163, gibt die vorliegende Doktorarbeit 
Aufschluss über die Rolle von verschiedenen CD163 Domänen bei der Bindung und 
Aufnahme von Hb-Hp Komplexen. Es konnte gezeigt werden, dass zusätzlich zu den 
bislang bekannten kritischen Domänen 3-6 auch Domäne 8 entscheidend für die 
Endozytose von Hb-Hp ist. Dies wird wahrscheinlich durch eine bisher unbekannte 
Rolle von Domäne 8 bei der Bildung oder Aufrechterhaltung der notwenigen 3D-
Struktur des Rezeptors für die Ligandenaufnahme bewirkt. 
Des Weiteren war es das Ziel dieser Doktorarbeit, die globale Langzeitantwort von 
Makrophagen auf die intensive Exposition mit Hb-Hp Komplexen, besonders im 
Hinblick auf die exklusive Rolle der Makrophagen bei der Hb- Beseitigung während 
der Hämolyse, zu untersuchen. Mit Hilfe von Genexpressionsanalysen und 
proteomischer Methoden gelang es, grosse Teile des umfangreichen Proteomes zu 
identifizieren und somit neue signifikante Eigenschaften von 
Wundheilungsmakrophagen zu definieren.  
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In dieser Dissertation konnte gezeigt werden, dass die Hb-Hp Exposition, welche das 
Freiwerden von Hb nach Gewebsverletzungen simuliert, eine supprimierte 
Expression von HLA Klasse 2 Molekülen auf Makrophagen hervorruft. Vermutlich 
verhindert dies die Präsentation von Autoantigenen gegenüber dem Immunsystem. 
Des Weiteren zeigten diese Makrophagen eine adaptive Antwort auf erhöhtes Hb 
durch verstärkte Expression von CD163 und Plasminogen Aktivator Inhibitor-2  
(PAI-2) mit einhergehenden zellschützenden und antioxidativen Mechanismen, die 
unter anderem durch induzierte Hämoxygenase (HO-1) und erhöhtes reduziertes 
Glutathion mit dem Ziel des Wiederherstellens der zellulären Homeostase 
gekennzeichnet waren. Interessanterweise haben die Makrophagen unter diesen 
experimentellen Bedingungen in hohem Masse chemoattraktiv wirkendes IL-8 
abgegeben, was vermutlich besonders Neutrophile zu den verletzten Geweben leiten 
soll. Die IL-8 Sekretion ist eine spezifische Antwort, welche explizit nicht im Rahmen 
einer gezielten Entzündungsreaktion steht. Im Einklang damit konnte das Fehlen von 
typischen NF-ĸB-abhängigen pro-inflammatorischen Mediatoren, wie TNF-α und  
IL-1β, im Kulturmedium dieser Makrophagen nachgewiesen werden.  
 
Zusammenfassend definieren die vorliegenden Ergebnisse einen neuen nicht-
inflammatorischen Makrophagenphänotypen mit einer hoher Hämoglobinaufnahme- 
und Beseitigungskapazität sowie anti-oxidativem Nutzen bei Entzündung und 
Wundheilung. 
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IV. Summary 
The oxygen carrier protein hemoglobin (Hb) is vulnerable to oxidative injury due to its 
reactive heme group. Only sequestration by the erythrocyte membrane enables the 
Hb to facilitate efficient oxygen delivery throughout the body. 
Cell-free Hb occurs in diverse quantities during e.g. erythrocyte destruction, tissue 
damage, sickle cell anemia and malaria. There are multiple clinical consequences 
following the release of massive amounts of free Hb in the circulation, among those 
are short-time observations such as oxidative denaturation of Hb, nitric oxide (NO) 
depletion, protein damage and renal failure. Long-term effects range from 
inflammation and hypertension to intraplaque hemorrhage in advanced 
atherosclerotic lesions. The primary Hb scavenger haptoglobin (Hp) instantly and 
effectively minimizes the multiple toxic effects of Hb by generating stable Hb-Hp 
complexes and triggering their clearance from the circulation by the macrophage 
CD163 receptor pathway.  
Given the important function of CD163 this thesis sheds light on the role of CD163 
receptor domains in Hb-Hp binding and uptake. In addition to the commonly known 
domains 3-6 that are sufficient for ligand uptake domain 8 was found to be essential 
for Hb-Hp endocytosis by CD163 suggesting this domain plays a role in the yet 
unknown 3D structure of CD163 crucial for Hb-Hp endocytosis. 
Further, this thesis aimed to investigate the long-term global response of 
macrophages extensively exposed to Hb-Hp with regard to the exclusive role of 
macrophages in Hb - clearance during e.g. tissue injury and hemolysis. By gene 
expression profiling and state-of-the-art proteomic approaches in order to discover 
the comprehensive macrophage proteome new significant characteristics of 
macrophages with a crucial role in wound healing could be identified.  
It could be shown that Hb-Hp exposure in order to mimic the Hb release in wounded 
tissues, profoundly suppressed HLA class 2 expression putatively avoiding auto-
antigen presentation to the immune system. Further, these macrophages displayed 
an adaptive response to wounding by increased expression of CD163 and 
plasminogen activator inhibitor 2 (PAI-2) with subsequent cell-protective and anti-
oxidative mechanisms characterized by e.g. induced heme oxygenase 1 (HO-1) and 
increased glutathione in order to recover the cellular homeostasis. Moreover, 
increased ferritin levels were observed indicating enhanced iron recycling activity in 
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these macrophages. Interestingly, the macrophages in these experimental setup 
released high amounts of the chemoattractant IL-8 putatively recruiting neutrophils to 
the wounded tissue sites. The majority of the detected genes characteristic for this 
macrophage phenotype is regulated by Nrf-2, a conserved oxidative transcription 
factor, indicating anti-oxidative potency of the stimulated macrophages. IL-8 
secretion is a specific response that is not in the context of a directed inflammatory 
response. This is in accordance with the absence of typical NF-ĸB-driven cytokines, 
such as TNF-α and IL-1β, as it was confirmed in the culture supernatants of these 
macrophages. 
 
In summary, the results presented herein define a new non-inflammatory 
macrophage phenotype with a high Hb-clearing capacity and anti-oxidative benefits 
in inflammation and wound healing. 
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1. General Introduction 
1.1. Hemoglobin and Hemolysis 
Hemoglobin (Hb) is one of the most abundant proteins in mammals and facilitates 
oxygen delivery from the lungs to the tissues. A single Hb-molecule is a tetramer that 
contains four heme-groups, each composed of protoporphyrin IX with a central iron 
atom. The iron exists in several redox states within the heme: the ferrous (Fe2+), 
ferric (Fe3+) and the ferryl (Fe4+) forms of iron. Only the ferrous state is able to 
reversibly bind oxygen, whereas the higher oxidation forms of iron, namely ferric and 
ferryl state are non-functional for oxygen transport as illustrated in Figure 1. Free Hb 
exerts toxic and inflammatory effects arising from oxidative processes involving the 
reactive heme group 1. The reducing environment within the erythrocytes prevents 
the deleterious activity of Hb 2.  
 
Figure 1 – Schematic illustration of the different oxidative states of heme iron. Each Hb 
molecule consists of four globin chains with a central iron atom. Hb oxidation results in 
changes of the iron’s oxidative state. The ferrous state (Fe2+) allows oxygen binding to 
deoxygenated Hb (deoxy Hb) at physiological conditions. The resulting oxygenated Hb (oxy 
Hb) can undergo autoxidation to methemoglobin (metHb) with a heme iron in the ferric state 
(Fe3+) and binds water instead of oxygen. Hydrogen peroxide can react with metHb to form 
ferrylheamoglobin (ferrylHb, Fe4+) (adapted from 3). 
When Hb tetramers are released from erythrocytes they dissociate spontaneously 
into Hb dimers that are easily oxidized into methemoglobin (Fe3+) which readily 
liberates its heme moiety 4. This leads, due to the hydrophobic nature of heme, to 
intercalation and passage of heme through cell membranes 3. The cellular uptake of 
heme provokes oxidative damage of plasma proteins by intracellular generation of 
reactive oxygen species (ROS), such as superoxide anion (O2
-) and hydrogen 
peroxide (H2O2). In erythrocytes, specific mechanisms protect against ROS damage. 
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Cytosolic enzymes such as catalase (CAT) and superoxide dismutase (SOD) 
detoxify ROS, whereas membrane antioxidants, namely vitamin A and E, protect 
against ROS-induced lipid peroxidation 5. Several studies demonstrated that cell-free 
Hb intensifies the toxicity and lethality of LPS by enhancing the biological activity of 
LPS with subsequent augmented TNF-α production 6-7. In 2004, D‟Agnillo 8 could 
show that redox active Hb (Fe4+) exacerbates LPS-induced apoptosis. In contrast, 
LPS binding to globin (Hb minus heme) attenuates LPS effects 9. Free Hb has an 
established pathophysiological role in hemolytic anemias such as sickle cell disease 
and malaria 10. Also, atherosclerosis with intraplaque hemorrhage and autoimmune 
hemolysis has very distinct links to cell-free Hb and heme reactivities 11-12. In 
summary, all Hb-related disorders share typical characteristics, such as oxidative 
denaturation of Hb, membrane lipid and protein oxidation, hemolysis and the release 
of Hb into the circulation 13-14. Taken together, the multiple toxic effects of Hb 
mandate an efficient physiologic Hb scavenge- and clearance system.  
Figure 2 summarizes the hemoglobin toxicity, involved scavenger proteins, and 
detoxification pathways which are described in detail below. 
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Figure 2 - Scheme of compartmentalized hemoglobin toxicity, scavenger proteins, and 
detoxification pathways. Free Hb can be released from the erythropoietic compartment and 
accumulates in the plasma and extracellular compartments during hemolysis or after tissue 
injury. In the extracellular compartment, Hb can react with peroxides (H2O2 and 
lipidperoxides) and promotes oxidative tissue damage. In the plasma compartment, 
extracellular Hb is sequestered in the Hb-Hp complex. Complex formation prevents Hb-
induced hypertensive and oxidative reactions. The Hb-Hp complex is subsequently 
endocytosed by the macrophage Hb scavenger receptor CD163. Within the macrophage, 
heme is released from globin and degraded by HO-1 into the antioxidant and anti-
inflammatory products bilirubin and carbonmonoxide (CO). The released iron induces ferritin 
synthesis. Iron can either be exported for iron recycling to the bone marrow or it can be 
stored in a ferritin complex. Additionally, the hemopexin (Hpx)-heme complex receptor (LDL 
receptor related protein, LRP) pathway can detoxify free heme that is released from oxidized 
Hb (adapted from 15). 
1.1.1. Erythropoietic compartment 
The bottom left box (red) illustrates the erythropoetic compartment where the late 
stage of erythroid development takes place. It is mainly characterized by the 
production of the major oxygen carrier adult Hb A, a tetramer consisting of two pairs 
of α-globin and β-globin protein subunits. Each subunit is bound to a heme moiety 
and they remain unstable and cytotoxic till final assembly to the tetrameric (α2β2) 
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hemoglobin 16. In detail, monomeric α-chains generate ROS that damage cellular 
proteins, lipids, and nucleid acids. In addition, they are easily denaturated upon 
oxidation causing deleterious accumulation of precipitated α-globin polypeptides, free 
heme, porphyrins and iron in cytoplasm and cell membrane 17. To prevent 
precipitation of premature Hb A subunits before assembly the chaperon α-
hemoglobin-stabilization protein (AHSP) captures newly synthesized Hb α-globin 
chains forming the AHSP complex. Subsequently, AHSP slowly and safely releases 
α-globin chains into the higher-affinity αβ-globin interaction. 
1.1.2. Plasma compartment 
When free Hb occurs during intravascular hemolysis (upper left box), it is 
immediately captured by the acute phase protein haptoglobin (Hp) forming a non-
covalent and stable complex with an extremely high affinity (1 x 10-15 mol L-1) that 
can be considered irreversible 18-19. The physiological importance of Hb-Hp formation 
lies mainly in the prevention of heme iron-driven oxidative damage and inflammation. 
Also, Hp-complexed Hb is not eliminated by glomerular filtration and prevents renal 
damage 20-21. Furthermore, extracellular Hb can rapidly react with NO 22. In sickle cell 
disease or malaria chronic hemolysis with high levels of cell free Hb is associated 
with diminished NO bioavailability leading to hypertension and other vascular 
outcomes. Once formed, Hb-Hp complexes are quickly removed from the circulation 
in the spleen (90%) and by circulating monocytes/macrophages (10%). 
Hp is mainly produced by hepatic cells 23 and occurs in the plasma of all mammals. 
In bony fish, there is a Hp-like protein (32-34% identical to human Hp), whereas 
neither in chicken nor frog a gene coding for a protein similar to human Hp was found 
24. In humans, Hp is characterized by a genetic polymorphism with three structurally 
different major phenotypes (Hp 1-1, Hp 2-1 and Hp 2-2) which arise from the 
polymorphic Hp locus (Hp1 and Hp2). Hp 1-1 is a smaller, more abundant dimer (86 
kDa), whereas Hp 2-1 is characterized by heteropolymers (86–300 kDa), and Hp 2-2 
forms large macromolecular complexes (170–1000 kDa) 21. The hepatic "clearance" 
of free Hb in plasma appears to be less efficient for Hp 2-2 than for the other Hp 
phenotypes 20. Also, the Hp2-2 phenotype has been associated with increased iron 
accumulation in hemochromatosis suggesting an influence of Hp phenotypes in iron 
homeostasis (reviewed in 21).  
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The protective antioxidative effect of Hp was recently investigated by Boretti and co-
workers 25 showing that Hp binding to Hb prevents the generation of oxidant species 
from cell free Hb mediating hypertension perhaps by capturing Hb as high-molecular 
weight complexes that cannot extravasate into the sub-endothelial sites. 
Nevertheless, Hp has also been reported to be involved in modulating immune 
responses, autoimmune diseases and inflammatory disorders 26-28 
1.1.3. Cellular compartment – The Hb/CD163/HO-1 pathway in macrophages 
First, it was thought that the clearance of Hb-Hp complexes exclusively occurs in 
both liver and spleen. Kristiansen and co-workers 29 identified the scavenger receptor 
CD163 as the only high-affinity receptor for Hb-Hp during search of the endocytotic 
receptor for Hb-Hp within the liver. The upper right box (blue) illustrates how the 
formed Hb-Hp complex is immediately cleared by high affinity binding to CD163, 
exclusively expressed on monocytes and tissue macrophages, leading to 
endocytosis and degradation of the complex 30. Moreover, in case of Hp-depletion as 
it appears during severe hemolysis, non Hp-complexed Hb is also scavenged 
through a low-affinity pathway by CD163. By means of competitive uptake 
experiments it could be shown that Hb binding to CD163 also inhibits Hb-Hp uptake 
suggesting that both Hb and Hb-Hp have a common binding site within the CD163 
molecule 31-32  
Once the Hb-Hp complex or free Hb is endocytosed, Hb-derived heme is degraded 
and transported through an endosomal/lysosomal pathway towards the cytoplasm 
while the globin is undergoing proteolysis. There, heme oxygenase 1 (HO-1), the 
inducible isoform of HO, catalyzes the heme by oxidation to biliverdin, which is 
further converted to bilirubin, CO and free ferrous iron, which is immediately 
sequestered by ferritin 33. All three byproducts (ferritin, bilirubin and CO) are known to 
have antioxidant properties and can protect the cell from oxidative damage and cell 
death 34-35. 
 
Upon inflammatory stimulus, including bacterial endotoxins and activation of the Toll-
like receptors TLR2, TLR4 or TLR5, the ectodomain is shed from the cell surface by 
a metalloproteinase-dependent mechanism 36-38 releasing soluble CD163 (sCD163). 
High levels of sCD163 are detected upon experimental endotoxin administration 37 
and during macrophage activation syndrome 38. Unlike LPS, free Hb has no effect on 
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CD163 cell surface expression on macrophages. This is in agreement with the 
common opinion that the receptor is not degraded after endocytosis but, instead 
recycles back to the cell surface after delivering the cargo to early endosomes 
(Figure 3). 
 
Figure 3 - CD163 functions as a scavenger receptor for Hb-Hp complexes or Hb alone. 
Hb-Hp uptake induces CD163 and HO-1 expression and a subsequent anti-inflammatory 
response. After internalization CD163 recycles back to the surface (adapted from 39). 
Furthermore, Fabriek and co-workers 40 could show that CD163 directly supports 
interactions with erythroblasts and identified a motif in the second SRCR domain 
responsible for mediating the binding of CD163 to erythroblasts. They also suggest 
that CD163 on liver and spleen macrophages could have dual function, namely the 
clearance of Hb and promoting erythropoiesis that could provide the recycled iron to 
developing erythroblasts.  
About a year later, Fabriek and co-workers 41 could identify another function of 
CD163. Starting from the point that cross-linking of CD163 with monoclonal 
antibodies directed against CD163 triggered the production of inflammatory 
mediators, such as NO, TNF-α, IL-1β and IL-6, indicated a role of CD163 in immunity 
and host defense 42-43. They could provide evidence that CD163 functions as a 
receptor for bacteria, including gram-negative and gram-positive species. 
Interestingly, motifs in the second and to a lesser extend in the third domain of 
CD163 were observed to be the bacteria binding site.  
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1.2. Monocytes/Macrophages 
Leukocytes are a diverse group of cell types that have critical roles in the immune 
response of the body. They circulate through the blood and the lymphatic system and 
are recruited to sites of tissue damage and infection. Leukocytes have a common 
origin in hematopoietic stem cells and develop along distinct differentiation pathways 
in response to internal and external signals into different subsets bearing distinct 
functional and physical characteristics 44. 
Monocytes in the steady state do not proliferate but circulate in the blood and reside 
in the bone marrow and in organs such as spleen and liver 45. Table 1 illustrates the 
two major subsets of human blood monocytes that vary in chemokine receptor (CCR) 
and adhesion molecule expression, as well as in migratory and differentiation 
properties 46. Classical monocytes (CD14++, CD16-) are more likely to become 
macrophages, while non-classical monocytes (CD14+, CD16+) in turn could develop 
to dendritic cells (DCs) 47.  
Table 1: Characteristics of classical and non-classical monoycte subsets described in 
humans.  
Classical Monocytes Non-classical Monocytes 
CD14++, CD16- CD14+, CD16+ 
CCR2+, CD64+, CD62L+ CCR2-, CD64-, CD62L- 
MHCII + MHCII ++ 
Monocytes themselves are already effector cells and once activated they become 
macrophages and produce inflammatory cytokines, ingest cells and toxic molecules 
with a half-life in blood of about 3 days 48 They are also highly involved in antigen-
presenting and T- and B-cell cooperation. Migration of monocytes to tissues and 
differentiation to DCs or macrophages is dependent on the microenvironment within 
the tissue sites 49.  
Macrophages polarize towards distinct morphological and functional characteristics 
(Figure 4) depending on the cytokines and microbial products in the 
microenvironment. 
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Figure 4 – Resident macrophages display a variety of functions. Clockwise from upper 
left: Macrophages are key players of innate defense against pathogens by generating an 
inflammatory and respiratory burst; they initiate antigen- presentation to activate adaptive 
immune response; macrophages clear immune complexes by uptake; they promote wound 
healing by release of growth factors; red pulp macrophages in the spleen are highly 
specialized for clearance of aged red blood cells; another subset of macrophages located in 
the bone so-called osteoclasts and is critical for remodelling of bone (adapted from 50).  
Mature macrophages can be classified into classically activated macrophages (M1) 
and alternatively activated macrophages (M2). Further, the more heterogeneous M2 
macrophage population can be divided into sub-phenotypes: M2a, M2b and M2c 51. 
While M2a macrophages are activated upon T helper 2 (TH2) cytokines IL-4 and IL-
13, the M2b sub-phenotype is induced by immune complexes or toll-like receptors 
and has a role in tissue repair during wound healing. M2c macrophages are induced 
in response to IL-10 or glucocorticoids resulting in decreased antigen presentation 
and increased immunosuppression 52 (Figure 5). 
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Figure 5 – Different macrophage subsets are induced dependent on a distinct cytokine 
environment. APC, antigen presenting cell. TLR, Toll-like receptor (adapted from 53).  
Classically activated macrophages arise in response to the cytokine IFN-γ produced 
by T helper 1 (TH1) cells or natural killer (NK) cells. This activation can be mediated 
by IFN-γ alone or in combination with microbial products (e.g. LPS) or cytokines (e.g. 
TNF) which further leads to shedding of CD163 (sCD163). Additionally, those 
macrophages have a high capacity in antigen presentation 54. In contrast, the 
synthesis of CD163 in macrophages is potently induced by anti-inflammatory signals 
such as IL-10 or glucocorticoids 55. However, T helper 2 (TH2) cell cytokines (IL-4/ 
IL-13) completely down-regulate CD163 expression and polarize macrophages into 
another alternatively activated phenotype. Of note, mature tissue macrophages, such 
as Kuppfer cells in the liver, red pulp macrophages in the spleen and cortical 
macrophages in the thymus, show a significantly higher expression of CD163 than 
peripheral blood monocytes indicating that CD163 expression may also increase 
along the macrophage differentiation 56-57. CD163 positive macrophages are found 
during the healing phase of acute inflammation, in chronic inflammation and in wound 
healing tissue 58-59. So far, it seems reasonable that macrophages high in CD163 
expression refer more to an anti-inflammatory phenotyp. Moreover, the phenotype of 
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macrophages remains adaptable allowing the switch between sub-populations in 
response to present stimuli in the microenvironment 53. 
1.2.1. A novel macrophage phenotype in wounding 
Monocytes are among the first cells to arrive in injured tissue where they differentiate 
into macrophages and ingest apoptotic cells to avoid secondary necrosis and thus 
inflammation. In case of RBC extravasation and in situ lysis, macrophages scavenge 
Hb-Hp by CD163 and degrade heme via induced HO-1. Boyle and colleagues 12 
could show that Hb-Hp uptake of macrophages during intraplaque hemorrhages in 
atherosclerotic lesions provoked the selective secretion of anti-inflammatory IL-10 
and down-regulation of HLA class 2 molecules. HLA class 2 molecules are key 
players in induction and regulation of adaptive immunity to pathogens and exhibit 
constitutively low level expression on macrophages until induction by IFN-γ. Both, 
constitutive and regulated HLA class 2 expression is controlled by the activity of the 
transcriptional transactivator CIITA 61. It has been shown in vitro that IL-10 is both, a 
potent inducer of CD163 and an inhibitor of HLA class 2 expression on 
macrophages. Diminished expression of HLA class 2 leads to subsequent impaired 
antigen presentation and activation of TH1 cells 
62-63
.  
In summary, the plasticity of macrophages is challenging and assigning specific 
biochemical markers to each population is difficult. Little attention has been paid to 
the hypothesis that extracellular Hb itself could be a modulator of macrophage 
phenotype polarization in wounded tissues. Therefore, we present a specialized 
macrophage phenotype with a distinct in vivo function in wound healing and 
atherosclerosis in this thesis. 
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1.3. Outline of the thesis 
Macrophages play a crucial role in wound healing processes and control of 
inflammation after tissue damage. Moreover, macrophages have the unique ability to 
clear and detoxify extracellular Hb through the macrophage-specific scavenger 
receptor CD163 during pathological events such as hemolysis and intraplaque 
hemorrhage. Nevertheless, not much is known about this highly specialized Hb 
clearing macrophage phenotype.  
 
Therefore, the specific aims of the research projects of this PhD thesis were: 
 
 
 1. To characterize the CD163 receptor SRCR domains in Hb-Hp binding and 
uptake outlined in chapter 2. 
 
 2. To characterize the macrophage proteome after long-term Hb-Hp exposure 
and to describe the generated phenotype outlined as a submitted manuscript 
in chapter 3. 
 
 3. To determine and characterize the impact of the Hb-Hp clearance pathway 
on the transcriptome of tissue macrophages outlined as a prepared 
manuscript in chapter 4. 
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2. Characterization of CD163 scavenger receptor cysteine rich 
(SRCR) domains critical in Hb-Hp binding and uptake 
2.1. Abstract 
Chapter 2 summarizes the efforts to design several truncated CD163 constructs 
(pseudo-receptors) and set up functional assays in order to identify the SRCR 
domains important for Hb-Hp binding, uptake and endocytosis. So far, it could be 
shown that SRCR domain 3 of CD163 is critically involved in the calcium-dependent 
binding of Hp-Hb. In contrast, proteolytic cleavage in domain 3 inactivates ligand 
binding. By means of uptake assays with fluorescent Hb-Hp complexes we could 
show that besides the critical role of the third domain, also domains 5, 6 and 7 are 
significant for endocytotic receptor function. Surprisingly, a truncated version lacking 
only the ninth domain was unable to take up the Hb-Hp complex indicating a critical 
role for domain 8. Therefore, we assume that the 8th domain might need the 
presence of domain 9 to achieve a to date unknown 3D structure of the receptor 
essential for Hb-Hp binding and uptake.  
Characterization of CD163 domains  27  
2.2. Introduction 
CD163 belongs to the scavenger receptor cysteine-rich (SRCR) superfamily, a highly 
glycosylated sub group of receptors belonging to the class of pattern recognition 
receptors. SRCR domains define the extracellular part of these transmembrane 
glycoproteins which are well conserved across multiple species 1. CD163 exists in 
two variants, class A and B that only differ in the spacing between the cysteines. 
While CD163 belongs to the variant B receptors, it bears several splicing variants 
within that subclass. The predominant splicing form of the human scavenger receptor 
CD163 is a 130kDa protein consisting of an ecto-, transmembrane- (22 amino acids) 
and cytoplasmic domain as indicated in Figure 1. The large extracellular domain 
contains a signal sequence of 41 amino acids and 9 scavenger receptor cysteine rich 
domains (1009 amino acids). The cytoplasmic region exists as a short variant (39 
amino acids) or as two long variants (84 and 89 amino acids, respectively) 2-4. All 
three isoforms exhibit a common sequence located after the trans-membrane domain 
for phosphorylation and signal transduction involving protein kinase K and caseine 
kinase II 5. The significance of the intracellular domain during the entry of the PRRS 
Virus was recently investigated by Lee and co-workers 6 which described an 
increased virus susceptibility of cells transfected with a tailless CD163 suggesting an 
important but yet unknown function. 
 
Besides its ability to bind several other ligands as discussed in the general 
introduction chapter, this chapter focuses on the exclusive function of CD163 to bind 
and endocytose Hb-Hp in order to clear toxic Hb from the circulation and recycle 
heme-iron. The binding of Hb-Hp to CD163 was previously investigated assuming a 
critical role of domain 3 in ligand binding 7. Furthermore, ligand-receptor binding was 
shown to be calcium dependent 8. In order to define structural and functional 
important domains in the CD163 molecule, Schaer and colleagues 1 characterized 
the mouse homologue of human CD163 by SRCR sequence alignment indicating a 
highly conserved region between the fourth and sixth domain within the receptor. The 
soluble chicken Hb-binding protein (Pit54), also a member of the scavenger receptor 
cystein-rich protein family 9, shows sequence similarity between domains 4-6 and the 
first domain supporting the critical role of domains 4-6 in ligand binding. Upon 
inflammatory stimulus the ectodomain is shed from the cell surface by a 
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metalloproteinase-dependent mechanism 10-12 releasing soluble CD163 (sCD163) 
that covers 94% of the total extra-cellular part. Surface plasmon resonance (SPR) 
measurements with immobilized recombinant sCD163 showed a high-affinity binding 
to Hb-Hp while sCD163 in solution only weakly competed for Hb-Hp uptake by 
CD163-expressing cells 13. Based on these findings, Moeller and colleagues 
assumed that only membrane bound CD163 effectively binds Hb-Hp because of 
possible receptor cross-linkages. 
Therefore, we chose to sub-clone 12 truncated versions of CD163 composed of the 
signal peptide, the transmembrane domain and the cytoplasmatic tail into an 
EmeraldGFP-containing vector. Sequence checked constructs were expressed in 
HEK cells and full length CD163 served as positive control for Hb-Hp uptake assays. 
We observed a subsequently increasing binding and uptake rate of the contructs 1-5, 
1-6 and 1-7, while 1-8 failed to endocytose Hb-Hp. These pre-eliminary results give 
more insights of possible conformational requirements sufficient for Hb-Hp uptake 
adding domain 8 as another critical region for ligand binding. 
2.3. Methods 
2.3.1. CD163 pseudo-receptor plasmid construction 
CD163 pseudo-receptors were amplified from a human CD163 cDNA clone (OriGene 
Technologies, Rockville, MD, USA) by two subsequent PCR‟s using AccuPrime 
Polymerase with the primers listed in Table 1 according to the cloning strategy 
illustrated in Figure 2. PCR products were sub-cloned into the expression vector 
pcDNA6.2/C-EmGFP/YFP-GW/TOPO (Invitrogen, Basel, Switzerland), and vector 
integrity was verified by nucleotide sequencing. Plasmids were transformed using 
TOP10 One Shot chemically competent E.coli cells (Invitrogen) and plasmid DNA 
was isolated by S.N.A.P. MidiPrep Method (Invitrogen), sequenced and linearized 
with Sca I (Roche diagnostics, Rotkreuz, Switzerland) before transfection. The 
following twelve constructs designated according to their CD163 SRCR domains 
were sub-cloned and expressed 1: CD163 1-3 (aa 1-366); CD163 1-4 (aa 1-469); 
CD163 1-5 (aa 1-574); CD163 1-6 (aa 1-681); CD163 1-7 (aa 1-815); CD163 1-8 (aa 
1-920); CD163 1-9 (aa 1-1024); CD163 3-4 (aa 258-496), CD163 3-5 (aa 258–574); 
CD163 3-6 (aa 258-681); CD163 3-9 (aa 258-1024) and CD163 4-6 (aa 356-681). 
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2.3.2. Expression of recombinant CD163 pseudo-receptors 
HEK293A cells were transfected using Lipofectamine 2000 reagent (Invitrogen) in 
OptiMEM I Reduced Serum Medium (Gibco, Basel, Switzerland) according to the 
manufacturer‟s instruction. Stable transfected HEK293A clones were established by 
subsequent selection with 6ug/ml Blasticidin (Invitrogen). To obtain an uniform 
population of cells expressing CD163 pseudo-receptors, GFP-positive cells were 
separated by fluorescence activated cell sorting (FACS, FACS Aria, Becton 
Dickinson, Basel, Switzerland). After sorting, cells were passaged at least 5 times 
before performing experiments. CD163 pseudo-receptor expression was confirmed 
by quantitative real-time reverse transcription (RT-PCR). Additionally, GFP 
expression was confirmed by western blot using a polyclonal antibody against GFP.  
2.3.3. Hb-Hp complex uptake assay by HEK293A cells  
Highly purified HbA0 (Sigma) or Hp phenotype 2-2 (Sigma) were labelled with Alexa-
633 protein labelling kit (Molecular probes, Eugene, OR) as described before 14. To 
measure the uptake of the complex, cells were incubated with Hb-Hp (20ug/m) in an 
incubator at 37°C, 5% CO2 and 95% humidity for 45 minutes. All uptake assays were 
performed in cell culture medium without serum. Hb-Hp complexes were generated 
at a 1:1 (wt/wt) ratio 5 minutes before experimentation. After incubation with the 
ligand cells were trypsinized and washed 3 times with cold phosphate-buffered saline 
(PBS) to remove non-ingested Hb-Hp complexes. Uptake of the fluorescent ligand 
was then measured by flow cytometry using a FACSCalibur (BD Sciences, Basel, 
Switzerland) at 530nm excitation/530nm emission (GFP) and at 661nm 
excitation/616nm emission (Alexa-633).  
2.3.4. Immunfluorescence analysis of Hb-Hp complex uptake by HEK293A cells  
Cells were cultured on endotoxin-free, sterile, round 12-mm glass coverslips (Hecht-
Assistant, Germany), pretreated with 6.25 µg/cm2 poly-D-Lysine Hydro-bromide (BD 
Biosciences, San Jose, CA, USA) in 24-cluster wells and incubated with fluorescent 
Hb-Hp (20ug/ml) complexes as described above. After incubation, cells were washed 
3 times with PBS and fixed for 15 minutes in 2.5% Paraformaldehyde (Sigma, 
Deisenhofen, Germany). Cells were permeabilized for 1 minute with 0.1% Triton-X-
100 and washed three times with PBS. After blocking of nonspecific binding sites for 
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1 hour with 10% goat serum in PBS and nuclear counterstain using 10 µg/ml 4,6-
diamidino-2-phenylindole (DAPI; Sigma) coverslips were mounted onto a microcope 
slide using ProLong Gold Antifade (Invitrogen). Images were taken with the Axioskop 
2 microscopy system, equipped with an AxioCam MRC digital camera (Carl Zeiss, 
Feldbach, Switzerland) and AxioVision software, version 4.6.3. (Carl Zeiss).  
2.3.5. Surface Plasmon resonance (SPR) measurements 
SPR analysis of Hb-Hp complex binding to CD163 was carried out on a ProteOn 
XPR36 instrument equipped with ProteOn Manager Software (Bio-Rad Laboratories; 
Reinach, Switzerland). The ProteOn GLM sensor chips (General Layer, Medium 
capacity, Bio-Rad) were pre-conditioned according to the manufactuer‟s protocol 
(Bio-Rad) and activated with a 1:1 mixture of 0.4 M 1-ethyl-3- (3-dimethylamino-
propyl)carbodiimide hydrochloride and 0.1 M N-hydroxysulfosuchinimide in water.  
10 ug of recombinant CD163 or purified Hp 1-1 (Sigma) was immobilized in 10 mM 
sodium acetate, pH 4.0 and remaining binding sites were blocked with 1M 
ethanolamine, pH 8.5. The flow buffer contained 150 mM NaCl, 2 mM CaCl2 and 10 
mM HEPES with a pH of 7.4. Sensorgrams were generated using Hb-Hp 
concentrations ranging from 250-4000 nM or Hb concentrations ranging from 12.5-
200 nM in flow buffer. In case of immobilized CD163 the flow cells were regenerated 
with 1.6 M glycine –HCl, pH 3.0 for reruns.  
2.4. Results and Discussion 
2.4.1. Identification of SRCR domains in CD163 critical for Hb-Hp binding and uptake 
A panel of CD163 pseudo-receptors was expressed and stably transfected in 
HEK293A cells. Stable and uniform expression was obtained by selection with 
blasticidin and routinely FACS sorting of GFP-expressing cells. Figure 3 shows the 
quantitative assessment of fluorescent Hb-Hp complex uptake. Truncated CD163 1-5 
and CD163 1-6 showed a moderate uptake of Hb-Hp compared to HEK293A cells 
without the receptor. To our surprise, approximately 80% (Figure 4) of the cells 
expressing CD163 1-7 and CD163 1-9 were positive for Hb-Hp uptake and could only 
be exceeded by positive control cells (HEK293A CD163) (97%). The right panel of 
Figure 3 illustrates the inability of the indicated truncated CD163 receptors to take up 
Hb-Hp. CD163 1-3 and CD163 1-4 were negative for Hb-Hp uptake, only one domain 
longer, CD163 1-5 instead was already able to internalize the ligand supporting the 
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hypothesis that region 4-6 is critical for Hb-Hp binding. Moreover, truncated receptors 
lacking the first, second and also the third domain could not take up the ligand (see 
Figure 3). Nevertheless, the most surprising finding was the inability of CD163 1-8 to 
internalize Hb-Hp equal to HEK293A CD163-negative control cells. We further 
proofed by western blot that CD163 pseudo-receptors bear GFP as illustrated in 
Figure 5.  
The indicated characteristics of selected CD163 pseudo-receptor transfected cells 
were further verified by immunofluorescence (Figure 6) analysis of Hb-Hp uptake. 
HEK293A cells transfected with the full-length receptor showed strong uptake of 
fluorescent Hb-Hp complexes, while CD163 1-3 bearing cells did not endocytose the 
ligand. In contrast, CD163 1-5, 1-7 and 1-9 transfected cells were positive for Hb-Hp 
uptake and GFP-expression. 
Finally, we used recombinant human CD163 encoding the extracellular domain to 
investigate Hb-Hp binding on the immobilized receptor. Madsen and colleagues 
could show that ligand receptor binding is calcium- and pH-dependent. In detail, 
calcium-concentrations lower than 0.2 mM and pH less than 6.5 increased 
dissociation of Hb-Hp from CD163. We chose to use a running buffer with a calcium 
concentration of 0.5 mM and a pH of 7.4. As shown in Figure 7, we applied different 
concentrations of Hb-Hp to the receptor. After a short association phase of 60 sec, 
the complex dissociates biphasic. We visually observed a relatively fast dissociation 
followed by a very low dissociation phase. These results are in agreement with 
studies of Kristiansen and colleagues 8 and Buehler and co-workers 15. Nevertheless, 
the initial idea was to isolate and purify the truncated CD163 receptors in order to 
immobilize them on a sensor chip and investigate the binding capacity for Hb-Hp. 
Unfortunately, pseudo-receptor isolation with GFP beads returned too less sample 
for receptor coating. Receptor elution from GFP beads was performed with a non-
denaturating solution using a pH shift according to the manufacturer‟s instructions 
(Miltenyi Biotech, Bergisch Gladbach, Germany). We assume that the elution 
process might have interfered with the receptor conformation. Also, the suspension 
was still enriched with too many perturbing proteins. Immobilized polyclonal anti-GFP 
antibodies on the chip seemed promising to “fish out” the pseudo-receptors but failed 
due to insufficient receptor concentrations in the cell suspension. We further 
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speculated that GFP tagged to the receptor could interfere with its binding ability. 
Today, vectors are available that enzymatically release their GFP tag and could allow 
immobilization of truncated receptors in order to get more insights into CD163-Hb-Hp 
binding and endocytosis. Further experiments could also investigate the impact of a 
variation of the buffer composition e.g. in pH or calcium concentration. 
In conclusion, we successfully expressed twelve CD163 pseudoreceptors and 
subsequent investigated their Hb-Hp binding and endocytosis capacity. Further, by 
means of immunofluorescence and uptake assays, we could show that besides the 
critical domains 4-6, also the domain 8 plays a non-redundant role in ligand binding 
and uptake. Unfortunately, we were not yet able to isolate sufficient amounts of 
purified CD163 pseudoreceptors to perform SPR experiments. Nevertheless, to 
identify the crystallographic structure of CD163 and the CD163-Hb-Hp complex 
would give a lot more answers to the open questions in receptor conformation and 
may help to define the interplay between Hb subunits and the CD163 SRCR 
domains. We suggest that the established pseudo-receptors could serve as the basis 
of these investigations.  
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Table 1- Oligonucleotides used for cloning 
Primer 5’ – 3’ 
hCD163 80-104 for CTTTGGAATGAGCAAACTCAGAATG 
CD163 3Dom* rev ATAAAGGATGACTGACGGGAATCAGAACATGTCACGCCAG 
CD163 4Dom* rev ATAAAGGATGACTGACGGGAGGCTGAGCAGGTAATTTTGG 
CD163 5Dom* rev ATAAAGGATGACTGACGGGATCTTGAGCAGACTACTCCAACATC 
CD163 6Dom* rev ATAAAGGATGACTGACGGGACTGGTTTCCTGAGCAGATTACAGAGGCCA
C 
CD163 7Dom* rev ATAAAGGATGACTGACGGGATTCTGAGCAGATAACTCCCGC 
CD163 8Dom* rev ATAAAGGATGACTGACGGGAACATGTGATCCAGGTCT 
CD163 9Dom* rev ATAAAGGATGACTGACGGGATG 
CD163 3Dom* for ACTTCTCAGTGCCTGTTTTGTCACCAGTTCTCTTGGAGATCTGAGCCTGA
GACTGGTAG 
CD163 4Dom* for ACTTCTCAGTGCCTGTTTTGTCACCAGTTCTCTTGGAGATCTGGAGCTAA
GACTTAGAGGTG 
CD163-TM-CT 
(Synth EmMutPlus rev) 
GTTCATCTCCCGGTATTGAATTCTCTGTCTTCGCTTTTTAGCCAAGAAGA
ATAATGCGACGAAAATGGCCAACAGAACAACCCCAAGGATCCCGACTGC 
AATAAAGGATGACTGACGGGA 
CD163-SP 
(Synth 163SignPep for) 
CGCCGGAATGAGCAAACTCAGAATGGTGCTACTTGAAGACTCTGGATCT
GCTGACTTCAGAAGACATTTTGTCAACTTGAGTCCCTTCACCATTACTGT 
GGTCTTACTTCTCAGTGCCTGTTTTG 
* SRCR domain 
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Figure 1 – Schematic representation of the CD163 receptor. Shown are the SRCR 
domains and the indicated transmembrane domain (figure partly adapted from 2). SP: signal 
peptide, ID: scavenger interspersed domain. 
 
                        
Figure 2 - Cloning strategy for the generation of CD163 SRCR domain pseudo-
receptors. Variable numbers of SRCR domains were amplified from SRCR domain cDNAs. 
The primers used for the generation of gene specific amplicons contain a consensus primer 
sequence (red) which was used in a second PCR for the fusion of the CD163 signal peptide 
(SP) to the 5’ end of the SRCR domains as well as the CD163 transmembrane domain and a 
endocytosis mediating cytoplasmic tail (TM-CT) to the 3’ end of the SRCR domains. This 
construct was then cloned as a fusion protein with enhanced GFP which allowed protein 
expression control in HEK293A cells. 
 
Characterization of CD163 domains  35  
 
Figure 3 - Hb-Hp uptake levels of distinct CD163 pseudo-receptors. Uptake was 
analyzed by flow cytometry. HEK293A cells served as negative control for uptake, while 
CD163 FL transfected HEK293A were the positive control for ligand uptake. Upper panel: 
pseudo-receptors positive for Hb-Hp uptake. Lower panel: pseudo-receptors negative for Hb-
Hp uptake. 
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Figure 4 – FACS measurement of GFP (Alexa 488) expression and quantitative 
assessment of fluorescent Hb-Hp uptake (Alexa 633) of several CD163 pseudo-receptors 
after 45 minutes of incubation with the ligand (Hb-Hp). HEK293A is referred as negative 
control while HEK293A CD163 FL served as positive control. 
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Figure 5 – Confirmation of GFP expression in CD163 pseudo-receptor transfected 
HEK293A cells using western blot analysis against recombinant GFP.  
 
 
Figure 6 – Immunofluorescent assessment of Hb-Hp endocytosis (red) and GFP 
expression (green) of transfected HEK293A cells. (A) HEK293A CD163 FL served as 
positive uptake control. (B) – (E) truncated pseudo-receptors transfected HEK293A cells. 
Nuclei (DAPI, blue).  
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Figure 7 – SPR analysis of binding of Hb-Hp to immobilized recombinant human 
CD163 on a ProteOn sensor chip. At time point 0 (indicated by black arrow), Hb-Hp 
complexes were applied to the immobilized ligand in a dose dependent manner. Binding and 
dissociation was recorded with 0.5 mM CaCl2 in the flow buffer (pH 7.4).  
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3. Hemoglobin polarizes the macrophage proteome towards high 
Hb clearance, enhanced anti-oxidant capacity and suppressed HLA 
class 2 expression 
3.1. Abstract  
Monocytes/macrophages are the key cell compartment of hemoglobin (Hb) clearance 
during hemolysis and wound healing. The rapid elimination of free extracellular Hb is 
crucial to limit its severe toxic effects due to the highly-reactive heme group of Hb. 
Free Hb avidly binds to the acute-phase serum protein haptoglobin (Hp) and is 
eliminated by macrophages that respond with anti-inflammatory and anti-oxidative 
properties. Quantitative mass spectrometry (MS) enables comprehensive 
identification and quantification of protein expression in complex cell samples, such 
as macrophages. We investigated the protein profile of macrophages after exposure 
to Hb-Hp complexes using Isobaric Tags for Relative and Absolute Quantification 
(iTRAQ)-based protein quantification followed by two different and highly 
complementary mass spectrometry platforms (MALDI-TOFTOF and LTQ Orbitrap). 
We identified a total of 3691 proteins obtained from three healthy donors with a 
considerable fraction of 848 significantly up- and down-regulated (p < 0.005) proteins 
by Hb-Hp treatment. Moreover, our data represent the so far most complete 
macrophage proteome. Beyond the identification of major Hb responsive pathways in 
macrophages, we could show that Hb-Hp exposure profoundly suppressed HLA 
class 2 expression putatively reducing antigen presentation to the immune system 
and therefore preventing specific immune responses. In summary, our data suggest 
that the Hb-Hp driven macrophage polarization represents a specialized macrophage 
phenotype with distinct in vivo functions in wound healing and atherosclerosis.  
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3.2. Introduction 
Hemoglobin is released from red blood cells (RBCs) during hemolysis or when blood 
gets extravasated such as in wounded tissues, during hemorrhagic stroke or 
atherosclerotic intraplaque hemorrhage. As a result of heme‟s strong reactivity with 
physiologic oxidants such as hydrogen peroxide (H2O2) extracellular Hb can act as a 
pro-oxidant in extracellular environments 1-2. Peroxidative tissue damage emanating 
from these reactions as well as pro-inflammatory effects exerted by heme and 
oxidatively damaged Hb protein aggregates has been reported 3-4. Clearance of Hb 
from extracellular sites in concert with adaptive cellular responses tailored to 
attenuating the potentially damaging effects of Hb seem therefore essential. 
 
Several potent mechanisms have evolved to protect against systemic or local Hb 
toxicity. Haptoglobin (Hp) is the primary Hb scavenger in plasma that binds free Hb in 
an irreversible complex 5-6. When bound to Hp, Hb remains sequestered in the 
intravascular space and peroxidative processes are efficiently confined within the 
complex, thus shielding the environment from oxidative damage 7-8. Much less 
knowledge exists about Hp‟s function in extracellular spaces such as in a wound 
where multiple cell types can express and secrete Hp upon stimulation 9. However, it 
is known that Hp slows heme release, prevents formation of covalent protein 
crosslink products and protects the structural integrity of globin amino acids even 
during very severe oxidative impacts. The Hb-Hp complex is finally endocytosed by 
the CD163 scavenger receptor pathway that is strongly and exclusively expressed by 
circulating monocytes and macrophages 10-11. It has been previously noticed that 
CD163 links extracellular Hb exposure to high heme oxygenase (HO-1) expression, 
enhanced heme and iron metabolisms and associated short-term anti-oxidative 
adaption 12.  
 
Macrophages serve diverse functions during inflammation and wound healing. 
Circulating blood monocytes are attracted to injured tissue sites within short time of 
an inflammatory or mechanic impact and start to differentiate into mature tissue 
macrophages 13. It is mainly the tissue environment (e.g. secreted cytokines) that 
directs polarization of the considerable differentiation plasticity of these cells into 
either pro-inflammatory phagocytes that fight invading pathogens or into a cell type 
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that mediates non-inflammatory removal of damaged tissue debris while promoting 
wound healing 14. So far, little attention has been paid to the hypothesis that 
extracellular Hb itself could be a modulator of macrophage phenotype polarization in 
wounded tissues. 
 
In this study we investigated how the differentiation of monocyte derived 
macrophages is modulated by extracellular Hb:Hb exposure. To get a 
comprehensive overview of the macrophage proteome in general and the 
quantitative changes in protein abundances resulting from Hb exposure we adopted 
a shotgun proteome exploration strategy. iTRAQ based protein quantification was 
combined with dual-analysis of identical samples by two different and highly 
complementary mass spectrometry platforms (MALDI-TOFTOF and LC-ESI MS/MS 
on a LTQ-Orbitrap). As a result of the high yield of unambiguous protein 
identifications we report here the so far most comprehensive macrophage proteome 
coverage. We found that continuous Hb exposure polarized the macrophage 
proteome towards a phenotype with high Hb clearance and anti-oxidative capacity 
that is uniquely characterized by profoundly suppressed HLA class 2 expression. 
3.3. Materials and Methods 
3.3.1. Cell culture and experimental conditions 
Human monocytes were prepared from heparinized whole blood (100 U/ml) from 
different healthy volunteers by a Ficoll gradient separation (Ficoll-PaqueTM PLUS, 
Amersham Biosciences) and three washes with Mg2+/Ca2+ -free phosphate buffered 
saline (PBS; GIBCO Europe). Cells were suspended in Iscove‟s modified Dulbecco‟s 
medium (IMDM; GIBCO Europe) supplemented with 10% autologous human serum 
to prevent activation and seeded at a density of 107 cells/ml in 6-well tissue culture 
plates (Falcon Oxnard, USA). During 2 h under standard cell culture conditions 
(37°C, 5% CO2) in a SteriCult tissue culture incubator (Fisher Scientific, USA) 
monocytes adhered to the tissue culture plates. Afterwards, the cells were washed 
with Gey‟s balanced salt solution (Sigma, USA) to remove non-adherent cells and the 
remaining monocytes were stimulated with 2 mg/ml Hb/Hp or Hb. Endotoxin free Hb 
was obtained from Hemosol (Ontario, Canada). Hp (mixed phenotype) was from 
Sigma (Buchs, Switzerland). Macrophages derived from monocytes were kept in 
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IMDM containing 10% autologous human serum for 2 days and for 5 days for mRNA 
expression analysis, respectively. For protein expression analysis culture time was 
prolonged to 7 days. 
3.3.2. Sample treatment for iTRAQ analyses  
Human-blood derived monocytes were prepared from 3 healthy donors, as described 
before and cultured in IMDM (GIBCO, Europe), supplemented with 10% heat-
inactivated, pooled human serum from 8 healthy donors. For each tested condition 
(media alone or 2 mg/ml Hb-Hp) samples were prepared in 3 biological replicates as 
mentioned above, whereas each replicate was divided into two portions for 
experimental replicates. At day 7 of culture total cellular protein was extracted from 
human-blood derived macrophages, grown in 24-well plates. Supernatant was 
removed and cells were harvested by scraping using 100 µl CelLytic-M reagent 
(Sigma) supplemented with Complete Mini Protease Inhibitor (Roche Diagnostics). 
After three freeze-thaw cycles and sonication with a Branson Sonifier 250, cellular 
debris was removed by centrifugation at 16‟000 x g for 10 min. Protein concentration 
of each sample was determined using a protein Bradford assay (Bio-Rad, USA). 
Samples normalized to 60 µg of protein were precipitated by adding 1 volume of 
trichloroacetic acid (TCA) to 4 volumes of protein solution to a final concentration of 
10-12% w/v TCA and incubated at 4°C for 10 min. After centrifugation at 16‟000 x g 
supernatant was removed, pellets were washed three times with ice-cold acetone 
and dried in a heat block at 95°C for 10 min.  
3.3.3. iTRAQ labeling 
Pellets were reconstituted in 20 µl of dissolution buffer and 1 µl of denaturant 
according to the protocol of the iTRAQ manufacturer (Applied Biosystems, USA). 
Additionally, we added 4 µl of 6 M freshly prepared urea to the pellets. Disulfide 
bonds were reduced by adding 2 µl of reducing agent and blocked by treatment with 
1 µl of cysteine blocking reagent. A total of 60 µg of protein was digested overnight at 
37°C with trypsin (Promega, USA) in the ratio 1:10, trypsin to protein. Peptides were 
covalently modified for two hours with an isobaric tag reagent according to the 
following scheme: iTRAQ 114 (control macrophages), iTRAQ 115 (Hb-Hp treated 
macrophages), iTRAQ 116 (control macrophages) and iTRAQ 117 (Hb-Hp treated 
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macrophages) (Figure 1). After combining the iTRAQ reagent labeled peptides, the 
reaction was stopped by adding 10 µl of phosphoric acid (pH 2-3).  
3.3.4. SCX fractionation 
The Labeled peptides were fractionated by strong cation exchange liquid 
chromatography (SCX) using a Polysulfoethyl A 2.1 mm x 200 mm, 5 µm, 300 Å 
column (PolyLC, USA). Solvent A was 10 mM potassium phosphate, 25% acetonitrile 
(ACN), pH 2.7, and solvent B was 10 mM potassium phosphate, 350 mM potassium 
chloride, 25% ACN, pH 2.7. The iTRAQ labeled peptides were diluted in a ratio 1:4 in 
solvent A and applied to the SCX column. Chromatography was performed at a flow 
rate of 0.3 ml/min according to the following gradient: 0-10 min 0% solvent B; 10-60 
min 0-100% solvent B; 60-65 min 100% solvent B; 65-90 min 0-100% solvent A. For 
each HPLC run, 24 out of 27 fractions were collected and partially evaporated to 
remove ACN in a vacuum concentrator. The collected fractions were redissolved in 
5% ACN, 0.1% trifluoroacetic acid (TFA), combined to 8 pools (each pool contained 3 
fractions) and desalted with Sep Pak C18 cartridges (Waters, USA). The 8 labeled 
sample pools were dried in a vacuum concentrator and reconstituted in 10 µl of 3% 
(v/v) ACN /0.2% formic acid. 5 µl of each pool was transferred to a new tube and 
combined to 4 sample pools for MALDI-TOFTOF MS analyses. The remaining 
sample amount of the 8 pools was used to perform LTQ-Orbitrap MS. All procedures 
were carried out with the monocyte lysates from three healthy donors. 
3.3.5. Nano-LC separation and MALDI target plate spotting of tryptic peptides 
Peptide separation was performed on an Ultimate chromatography system (Dionex - 
LC Packings, USA) equipped with a Probot MALDI spotting device. 5 µl of the 
samples were injected by using a Famos autosampler (Dionex - LC Packings) and 
loaded directly onto a 75 µm x 150 mm reversed-phase column (PepMap 100, 3 m; 
Dionex - LC Packings). Peptides were eluted at a flow rate of 300 nl/min by using the 
following gradient: 0-10 min, 0% solvent B; 10-105 min, 0-50% solvent B; and 105-
115 min, 50-100% solvent B. Solvent A contained 0.1% TFA in 95:5 water/ACN , and 
solvent B contained 0.1% TFA in 20:80 water/ACN . For MALDI analysis, the column 
effluent was directly mixed with MALDI matrix (3 mg/ml -cyano-4-hydroxycinnamic 
acid in 70 % (ACN /0.1 % TFA) at a flow rate of 1.1 µl/min via a µ-Tee fitting. The 
matrix solution also contained neurotensin at a concentration of 125 pmol/ml (Sigma, 
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USA) for internal calibration. Fractions were automatically deposited every 10 s onto 
a MALDI target plate (Applied Biosystems/MDS Sciex, USA) using a Probot 
microfraction collector. A total of 416 spots were collected from each HPLC run. 
3.3.6. MALDI-TOFTOF mass spectrometry  
MALDI plates were analyzed on a 4800 MALDI-TOFTOF system (Applied 
Biosystems) equipped with a Nd:YAG laser operating at 200 Hz. All mass spectra 
were acquired in positive reflector mode and generated by accumulating data from 
800 laser shots. First, MS spectra were recorded from peptide standards, and the 
default calibration parameters were updated. Second, MS spectra were recorded for 
all sample spots on the MALDI target plate (416 spots per sample, 4 samples per 
plate). The MS spectra were recalibrated internally based on the ion signal of 
neurotensin peptide (Sigma, USA).  
The following threshold criteria and settings were used for the acquisition of MS/MS 
spectra: Mass range: 800 to 4000 Da; minimum signal-to-noise (S/N) for MS/MS 
acquisition: 100; maximum number of peaks/spot: 8. Peptide CID was performed at a 
collision energy of 1 kV and a collision gas pressure of approximately 2.5 x 10-6 Torr. 
During MS/MS data acquisition, a method with a stop condition was used. In this 
method, a minimum of 1000 shots (20 sub-spectra accumulated from 50 laser shots 
each) and a maximum of 2000 shots (40 sub-spectra) were allowed for each 
spectrum. The accumulation of additional laser shots was halted whenever at least 6 
ion signals with a S/N of at least 60 were present in the accumulated MS/MS 
spectrum, in the region above m/z 200. 
3.3.7. LTQ-Orbitrap measurements 
iTRAQ experiments were performed on a hybrid LTQ Orbitrap XL mass spectrometer 
(Thermo Scientific, Bremen, Germany) coupled to an Eksigent nano LC system 
(Eksigent Technologies, USA) and analyzed by reversed-phase liquid 
chromatography nanospray tandem mass spectrometry (nanoLC-MS/MS). Peptides 
were resuspended in 3% ACN and 0.2% formic acid, loaded from a cooled (10°C) 
Spark Holland autosampler (Emmen, Netherlands) and separated using an 
ACN/water solvent system containing 0.2% formic acid with a flow rate of 200 nl/min. 
Separation of the peptides was performed on a 10 cm long fused silica column (75 
µm i.d.; BGB Analytik) in-house packed with 3 μm, 200 Å pore size C18 resin 
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(Michrom BioResources, USA). Elution was achieved using a gradient of 3−48% 
ACN in 50 min, 48−80% ACN in 3 min and 80% ACN for 7 min. 
iTRAQ labeled peptides were analyzed by applying spectral merging of CID and 
HCD of two consecutive scans from the same precursor. One scan cycle was 
comprised of a survey full scan MS spectrum from m/z 300 to m/z 2000 acquired in 
the FT-Orbitrap with a resolution of R= 60„000 at m/z 400, followed by up to six 
sequential data- dependent CID and HCD MS/MS scans. CID was done with a target 
value of 1e4 in the linear trap. Collision energy was set to 35%, Q value to 0.25 and 
activation time to 30 ms. HCD fragmentation ions including reporter ions were 
detected in the Orbitrap with a target value of 5e5, and a collision energy of 43%. For 
all experiments dynamic exclusion was used with one repeat count, 30s repeat 
duration and 90s exclusion duration. The instrument was calibrated externally 
according to the manufacturer's instructions. The samples were acquired using 
internal lock mass calibration on m/z 429.088735 and 445.120025. 
3.3.8. Peptide and protein identification and quantification by database searching 
Raw spectra were processed with Mascot Distiller 2.2 (Matrix Science, London, UK) 
and protein identification and quantitation was performed using Mascot Version 2.2.0 
(Matrix Science) as the search engine. Mascot generic files were searched against a 
SwissProt human protein sequence database downloaded from 
ftp.ebi.ac.uk/pub/databases/SPproteomes (database release February 11, 2009; 
117865 protein sequences (with 56722 forward and reverse sequences, respectively, 
and 259 contaminant sequences).  
The following search settings were used for both methods: maximum missed 
cleavages: 2; maximum number of signals per spectrum: 55. For MALDI-TOFTOF 
MS the peptide mass tolerance was set to 25 ppm and fragment ion tolerance was 
0.3 Da. In contrast, for LTQ-Orbitrap the peptide mass tolerance was 10 ppm and the 
fragment ion tolerance was set to 0.8 Da. iTRAQ4plex reagent labeling of lysine and 
of the N-terminal amino group of peptides and methylmethanthiosulfonate (MMTS)-
labeled cysteine were specified as fixed modifications, oxidation on methionine as 
variable modification. For the quantitation of iTRAQ labeled peptides the isotopic 
correction factor was used as supplied by the manufacturer (Applied Biosystems). 
iTRAQ ratios of proteins were median normalized and protein ratios were determined 
as the geometric mean of the peptide ratios. False discovery rates (FDR) were 
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estimated by searches against a corresponding database containing forward and 
reversed sequences, according to the method of Kall 15. Further analysis of 
proteomics data were performed using MATLAB 7.7.0. software (The MathWorks 
Inc., Bern, Switzerland). 
3.3.9. Flow cytometric analysis 
Human-blood derived monocytes were prepared from buffy coats of healthy blood 
donors (Swiss Red Cross, Schlieren, Switzerland), as described previously 16 and 
seeded into 12-well tissue culture dishes and stimulated with 2 mg/ml Hb-Hp. At day 
7 of culture, cells were harvested by scraping and washed three times with 
PBS/0.1% BSA. Cells were stained with HLA-DR, CD14, CD86 and CD163 
antibodies. Mouse IgG1 ĸ – APC (BD Pharmingen), Mouse IgG1 ĸ – PE (BD 
Pharmingen) and Mouse IgG1 ĸ – FITC (BD Pharmingen) were used for isotype 
controls. At least 10‟000 events per sample were acquired by FACSCanto scan flow 
cytometer (BD Biosciences, San Jose, USA) using FACS Diva software. Raw data 
were analyzed using FlowJo 7.2.5. software (Tree Star, USA) and geometric mean 
fluorescence intensity was normalized to the corresponding isotype control.  
3.3.10. Statistics 
Proteomics data were analyzed as described above. Confirming and functional data 
are expressed as mean ± standard error of mean. Significance was calculated by t-
test or one-way ANOVA. (Graphpad Prism version 4.0.). 
3.4. Results and Discussion 
We cultured human peripheral blood derived monocytes in Hb-Hp enriched (2 mg/ml) 
medium to mimic conditions that these cells might encounter within wounded tissues 
or within an atherosclerotic plaque hemorrhage. In all these conditions massive 
amounts of Hb can be released from extravasated red blood cells while Hp enters the 
site either as a plasma-derived protein or from local cellular secretion. In our 
experiments we used Hb-Hp complexes instead of free Hb to avoid uncontrolled 
oxidative side reactions that could eventually occur during prolonged cell culture. We 
performed a shotgun proteomic analysis with iTRAQ based relative quantification to 
comprehensively characterize the macrophage proteome as well as the more specific 
Hb-Hp induced changes in protein expression. By combining the benefits of the 
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commonly used MALDI-TOFTOF for iTRAQ experiments with parallel analyses on an 
LTQ-Orbitrap XL we could significantly improve the overall yield of identified 
peptides/proteins. Additionally, this set-up offered the unique possibility of a cross-
platform validation of the biologically most relevant results.  
3.4.1. Proteomic profiling of monocyte-derived macrophages 
In a combined analysis of all the data generated by the two platforms we could 
identify and relatively quantify a total of 3692 proteins across all conditions and at the 
level of stringency detailed above. To our knowledge this is the most comprehensive 
proteome coverage of human monocytes or macrophages reported so far 17-19. 
Figure 2 illustrates the sub-cellular classification of the total detected macrophage 
proteome using PANTHER classification software (www.pantherdb.org/). The 
identified proteins were compared to a reference list (19911 homo sapiens genes) in 
order to statistically determine over-and under-representation of PANTHER 
classification categories (Table 2). Among 3692 hits, a considerable fraction of 1449 
proteins occurred in both, the MALDI-TOFTOF and Orbitrap lists. However, 1047 
proteins were exclusively identified with the MALDI-TOFTOF instrument while LTQ-
Orbitrap measurements resulted in additional 1593 exclusive protein observations. 
Earlier studies using 2D gel electrophoresis (2DE) with subsequent LC-MS/MS 
analysis could represent only a small fraction of the monocyte proteome mostly due 
to the limited resolution of complex proteomes in the gels 20. A recent study of Zhang 
and co-workers 21 revealed 1651 macrophage proteins obtained from shotgun 
proteomics using iTRAQ with LC-MS/MS analysis. Still, we were able to identify and 
quantify about three times more proteins using iTRAQ labeling even without a time 
consuming sub-cellular pre-fractionation but, instead, by combining results from two 
complementary mass spectrometry technologies. 
 
After isolation from peripheral blood the monocytes were exposed to purified and 
endotoxin-free Hb-Hp (2 mg/ml) for seven days. Peptides derived from the Hb-Hp 
exposed cells were labeled with iTRAQ reporter tags 115 and 117, whereas control 
monocytes were labeled with reporter tags 114 and 116 (see Materials and 
Methods). The raw MS/MS spectra files obtained by either MALDI-TOFTOF or 
Orbitrap mass spectrometry were processed by Mascot Distiller and quantitatively 
analyzed by Mascot searches against a human SwissProt database that contained 
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the forward and reversed sequences of the human proteome. Two master XML-files 
were generated – one for MALDI-TOFTOF and one for Orbitrap data – that contained 
the experimental data of all replicate measurements including forward and reverse 
sequence hits. As a first step to validate the protein identifications, we estimated the 
theoretical false discovery rate (FDR) as a function of relative Mascot protein ID 
scores according to the method of Kall 15 and fitted a FDR function cfun(x) = 
a*exp(b*x) + c*exp(d*x) to each dataset. Based on these calculations we applied a 
FDR threshold at 5% and only identifications above this cut-off were accepted for 
further analysis. The FDR for the MALDI-TOFTOF data was below 5% even at the 
lowest ID score (Figure 3A) while LTQ Orbitrap data contained 3039 protein 
identifications with a protein ID score above the threshold of 49 corresponding to a 
FDR of 5%. Additionally, we only accepted proteins with at least two unique peptide 
identifications. In summary, the restrictive protein identification thresholds applied to 
our data included 1) at least two peptide identifications per protein 2) total Mascot ion 
score > 99% for MALDI-TOFTOF data, and 3) FDR < 5% for LTQ Orbitrap data. 
3.4.2. iTRAQ based protein quantification reveals a distinct macrophage phenotype 
polarization induced by Hb-Hp exposure 
Protein abundance ratios of all identified proteins were calculated based on extracted 
iTRAQ tag signal intensities. Since the linear range of MALDI-TOFTOF and LTQ-
Orbitrap quantifications seems not identical and therefore the range of protein 
regulations differed in the two datasets, we transformed the protein ratios into log10-
values and normalized them according to their median (m): normalized log(10) ratios 
(y) = (log(10)ratios/std(m)). Following normalization, we performed a t test on the 
log10(Hb-Hp-treatment/control) ratios against the mean value of the 
log10(control/control) ratios. In summary, proteomics analysis yielded a maximum of 
12 treatment/control and 3 control/control ratios. A total of 835 proteins with a p value 
less than 0.005 were considered to be significantly affected by Hb-Hp treatment 
compared to control ratios. Among these, 99 proteins were commonly identified by 
both MALDI-TOFTOF and LTQ-Orbitrap. MALDI-TOFTOF measurements detected 
additional 365 significantly regulated proteins, and by applying a second threshold of 
> 1.5 fold change 68 proteins were significantly up- and 35 were down-regulated 
proteins (Table 1). LTQ-Orbitrap analyses yielded 582 additional regulated proteins 
with 68 significantly up- and 86 down-regulated proteins (Table 1). The correlation 
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coefficient of the regulated proteins (p-value < 0.005) that were identified and 
quantified by both platforms was 0.94 (99 data points) (Figure 4D). 
To obtain more information on the sub-cellular location of proteins represented in our 
macrophage proteome in relation to the general functional gene ontology (GO) 
classifications, we generated an enrichment analysis against a GO annotated 
database, PANTHER classification system. We found significant enrichment of 
proteins located intracellular (p=6.23E-29) and associated to MHC complexes 
(p=8.55E-09). Other predominant clusters were associated with cytoskeleton 
(p=1.13E-18) and cytoplasm localization (p=2.13E-10). In contrast, we found an 
under-representation of proteins located extracellular (p=5.36E-04) and in the 
nucleus (5.60E-01) (see Table 2).  
In a next step we aimed to determine the functional proteome polarization induced by 
Hb-Hp by testing the list of either up- or down-regulated proteins against the list of all 
identified proteins (e.g. the macrophage proteome).  
3.4.3. Hb-Hp exposure promotes a macrophage phenotype with high Hb-heme 
degradation and anti-oxidant capacity 
We analyzed the normalized and significantly up-regulated proteins (p < 0.005 and 
fold change > 1.5) identified with MALDI-TOFTOF and/or LTQ-Orbitrap MS using the 
PANTHER Classification System. The list of all identified proteins served as a 
reference list (masterlist). From the 104 up-loaded proteins, 46 were recognized and 
found to be significantly over-represented (p < 0.005) in categories such as blood 
circulation (p=1.22E-08), immune system processes (p=1.74E-04), cell adhesion 
(p=6.81E-04), response mechanisms to stimuli (p=7.38E-04, p=8.28E-04, 
respectively) and in blood coagulation (p=7.38E-04), represented by the proteins 
plasminogen activator inhibitor 2 (PAI-2) and fibrinogen. Table 3 shows the particular 
biological processes with the number of expected proteins from the list of up-
regulated proteins compared to the masterlist. 
To our surprise, we found that the down-regulated proteins upon Hb-Hp treatment 
were mainly related to reduced antigen processing and presentation via human 
leukocyte antigen (HLA) class 2 (p=6.32E-12) (see Table 4).  
Figure 6 highlights the 50 top ranked up-regulated proteins identified with MALDI-
TOFTOF and/or LTQ-Orbitrap including HO1, ferritin, fibrinogen α and PAI-2. 
Additionally, enzymes with anti-oxidative properties to maintain the cellular 
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homeostasis like thioredoxin reductase 1 (TXNRD1), superoxide dismutase 1 (SOD) 
and vitamin D binding protein, which contributes to the anti-oxidative potency of 
vitamin D 22, were found among the top 50 up-regulated proteins in a concerted 
manner. Furthermore, Hp and several subunits of the Hb molecule appeared to be 
strongly induced since these compounds had been added to the system as stimulus 
before. Glutamine synthetase, a key enzyme for the assimilation of ammonium to 
amino acids bearing anti-oxidative properties, was also among the up-regulated 
proteins. Additionally, we found NAD(P)H:quinone oxidoreductase, (NQO1) which we 
previously described as a major cellular defense gene (submitted manuscript), to be 
up-regulated. In summary, the composition of the significantly up-regulated proteins 
upon Hb-Hp treatment is characterized by an adaptive response to wounding 
(CD163; PAI-2; fibrinogen) with subsequent cell-protective and anti-oxidative (HO-1; 
SOD; TXNRD1) mechanisms to recover the cellular (iron) homeostasis. 
 
Monocytes can differentiate into classically activated inflammatory macrophages 
(M1) that have a high capacity to secrete inflammatory cytokines and kill invading 
pathogens 23-24. At the other end of the continuous macrophage differentiation 
spectrum an “alternatively” activated macrophage phenotype (M2) has been 
characterized that is involved in down-regulation of inflammatory processes and 
wound healing 25. Yet another monocyte differentiation path leads to the generation 
of myeloid dendritic cells that are characterized by high-level expression of HLA class 
2 and potent antigen presenting function 26. The polarization of the different 
macrophage phenotypes is primarily determined by environmental factors. For 
example, T-cell derived IFN- is the principle classic macrophage activator leading to 
M1 polarization. A more heterogeneous group of mediators that is considered to 
have mainly anti-inflammatory properties such as IL-4 or glucocorticoids skew 
macrophage differentiation towards M2 polarization. So far, the Hb-Hp up-regulated 
protein clusters found in our study are compatible with a more “alternatively” 
activated macrophage phenotype with high Hb clearance and anti-oxidant capacity 
that might provide an active role in wound healing. A wounded tissue environment 
can be considered to be Hb rich and pro-oxidant. Therefore, the principle phenotype 
of the Hb-Hp induced macrophage described here seems to be biologically 
meaningful. Also, we found no evidence of inflammatory gene expression that would 
be compatible with M1 polarization.  
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3.4.4. Hb-Hp polarized macrophages are characterized by profoundly suppressed 
HLA–class 2 proteins 
PANTHER classification of the down-regulated proteins displayed a highly significant 
enrichment of negatively regulated proteins associated with antigen processing and 
presentation by HLA class 2 proteins (p=6.32E-12) (Table 4). Down-regulation of the 
human leukocyte class 2 isotypes (HLA-DR, HLA-DQ, and HLA-DP) is shown in 
Figure 7. 19 out of 28 HLA class 2 protein identifications detected with MALDI-
TOFTOF MS were significantly decreased (p < 0.005), none was found to be 
increased. Even a higher number of significantly down-regulated HLA class 2 
proteins could be found in the LTQ Orbitrap derived data (46 downregulated out of 49 
total identified; Figure 9B). We chose HLA-DRB1 (accession # P20039) and HLA-
DPB1 (accession # Q5SQ73) to further analyze the abundance ratios of their 
individual constituting peptides across duplicate control and treatment experiments 
performed with three independent donor monocytes. Figure 8A and B show the log10 
ratios of the peptides matching to HLA-DRB1 or HLA-DPB1 that were found in all 
three and two donors, respectively. The overall pattern of peptide ratios across all 
cell culture conditions, biologic replicates and individual donors clearly visualizes the 
down regulation of the “mother” protein. In contrast to HLA class 2, only one out of 
the four identified HLA class 1 proteins was found to be significantly suppressed.  
3.4.5. Transcriptional down-regulation contributes to HLA class 2 suppression by Hb-
Hp 
HLA class 2 expression is determined by transcriptional as well as by post-
transcriptional/post-translational mechanisms. Posttranslational processes affect cell 
surface expression, sub-cellular trafficking and lysosomal degradation and represent 
an important determinant of overall protein abundance. In contrast, the Class II 
transactivator CIITA controls expression of HLA class 2 at the genetic level and the 
expression of several genes encoding accessory proteins required for MHCII 
restricted antigen-presentation, namely the invariant chain (Ii), HLA-DM and HLA-DO 
27-28. CIITA transcription can be selectively activated by IFN-γ, LPS, and IL-4, and is 
downregulated by IL-10, nitric oxide, and TGF-β 29-30. By binding to the MHCII 
enhanceosome the transcription of HLA-class II genes is activated 31. 
We have therefore specifically analyzed HLA class 2 mRNA abundance and its 
regulation by Hb-Hp in an independent dataset of gene array experiments. These 
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data were derived from a comprehensive gene array experiments of macrophages 
cultured under control as well as high Hb-Hp conditions that were identical to the 
conditions of our proteome experiments. The major difference in the experimental 
set-up of these studies was that the mRNA expression was not examined at day 7 of 
cell culture but at days 2 and 5, accounting for the different dynamics of the 
synthesis, degradation and steady-state levels of mRNA and proteins, respectively. 
The gene array data are available at www.ebi.ac.uk/aerep/login (reviewer account 
login: Reviewer_E-MEXP-2820, Password: 1279719286410). 
Figure 9 shows a summary of mRNA expression levels of HLA class 1 and 2 (in 
relation to control levels in untreated cells) at days 2 and 5. While the log10 of the 
treatment-to-control ratio of HLA class 1 expression did not differ from 0 at either time 
point we found a statistically significant (p < 0.005) HLA class 2 mRNA suppression 
by Hb-Hp treatment. However, although these data suggest a minor, though 
sustained, transcriptional suppression of HLA class 2 mRNA, the very pronounced 
decrease in HLA class 2 protein levels (Figure 9B) are more likely the result of 
combined transcriptional/post-translational mechanisms. It might, for example, being 
speculated that the highly enhanced Hb-Hp endocytosis and breakdown might 
impact subcellular trafficking and degradation pathways shared between the two 
proteins. 
3.4.6. Immunophenotyping and cell viability assessment support macrophage 
proteome polarization towards high Hb clearance, increased anti-oxidative capacity 
and low HLA class 2 expression 
To confirm the Hb-Hp induced CD163high/HLA class 2low macrophage phenotype 
implicated by our proteome analysis we quantified by flow-cytometry the cell surface 
expression of CD163 and HLA-DR along with the macrophage differentiation marker 
CD14 and the co-stimulatory molecule CD86. After seven days of differentiation in 
the presence of Hb-Hp the PBMC derived macrophages displayed a significantly 
suppressed cell-surface HLA-DR expression while CD163 and CD14 were 
consistently enhanced in all experiments (Figure 10). Interestingly, cell surface 
expression of the co-stimulatory molecule CD86 which was not captured in our mass 
spectrometry exploration was also significantly lower in the Hb-Hp polarized cells. 
CD86 is essential for efficient antigen presentation 32-33 and along with the profound 
down-regulation of HLA class 2 the data suggest that Hb-Hp polarized macrophages 
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might have a reduced capacity to presenting antigens and stimulating specific 
immune responses. Although speculative, it might be suspected that while the Hb-Hp 
polarized macrophages support clearance of extracellular Hb, anti-oxidant protection 
as well as essential wound healing processes, the same cells were tailored to avoid 
accidental stimulation of immune responses that could potentially target auto-
antigens released in injured tissue environments. 
Since extracellular Hb can be a potential source of heme derived toxic radicals that 
could impede macrophage cell survival in our experiments it was essential to prove 
that the enhanced anti-oxidative protein cluster expression was also functionally 
reflected by an enhanced viability of Hb-Hp polarized cells compared to control 
macrophages (Figure 11B). 
The findings of our proteome analysis are in agreement with a recent study by Boyle 
and co-workers 34 that reproduced a potentially atheroprotective macrophage 
phenotype with high CD163 and low HLA class 2 expression (CD163high/HLA class 
2low) by culturing peripheral blood monocytes in the presence of Hb-Hp. These 
CD163high/HLA class 2low macrophages were consistently found in atherosclerotic 
coronary arteries with a particularly high density within areas of intraplaque 
hemorrhage. Functionally, these macrophages cleared Hb more quickly with less 
oxidative cell damage and increased cell survival. Therefore, the Hb-Hp driven 
macrophage polarization described here likely represents a specialized macrophage 
phenotype with a distinct in vivo function in wound healing and atherosclerosis. 
3.4.7. Conclusion 
Specialized macrophages have a critical role in controlling inflammatory responses 
induced by any form of tissue damage and at the same time in supporting wound 
healing. Macrophages are also the cell type that is uniquely capable to remove and 
detoxify extracellular hemoglobin through the CD163 Hb scavenger receptor 
pathway. So far, little knowledge was available how this Hb clearance function of 
macrophages could by itself impact the differentiation of these cells. In a 
comprehensive proteome exploration – which represents the so far most complete 
coverage of the macrophage proteome – we found that Hb-Hp exposure polarizes 
the macrophage phenotype towards increased expression of proteins associated with 
Hb/heme clearance and anti-oxidative functions. These changes were reflected by an 
increased viability of macrophages cultured in high Hb-Hp conditions. On the other 
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hand, Hb-Hp exposure profoundly suppressed HLA class 2 protein expression, 
putatively via inference with transcriptional as well as post-translational regulatory 
processes. It is therefore conceivable that the Hb-Hp induced CD163high/HLA class 
2low macrophage represents a specialized phenotype tailored to supporting Hb 
clearance, anti-oxidant protection and wound healing while avoiding presentation of 
released auto-antigens to the immune system.  
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Table 1 - Comparison of the number of proteins identified with MALDI-TOFTOF and LTQ-
Orbitrap mass spectrometry 
 Number of proteins 
Dataset Total a p < 0.005b 
up-regulated  
(p < 0.005, fold 
change >1.5) 
down-regulated  
(p < 0.005, fold 
change > 1.5) 
MALDI + Orbitrap* 1370 (37%) 99 (3%) 17 11 
MALDI 2203 (60%) 365 (10%) 68 35 
Orbitrap 2858 (77%) 582 (16%) 68 86 
All identified 
proteins 
3691 (100%) 848 (23%) 104 102 
a Protein hits with at least two unique protein identifications and a FDR <5%. b p < 0.005 
indicates significant difference in expression ratio upon Hb-Hp treatment. * Proteins identified 
in both MALDI-TOFTOF and LTQ-Orbitrap datasets. 
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Table 2 - PANTHER GO compartment classification 
 
 
No. of proteins classfied 
from masterlist   
Cellular 
Component 
Homo sapiens  
genes - (19911) observed expected 
over/under- 
represented P - value 
Unclassified 17808 2089 1886.25 + 1.98E-73 
intracellular 1192 264 126.26 + 6.23E-29 
protein complex 197 82 20.87 + 1.56E-24 
cytoskeleton 1003 205 106.24 + 1.13E-18 
actin cytoskeleton 415 109 43.96 + 4.11E-17 
ribonucleoprotein 
complex 
164 52 17.37 + 1.17E-11 
vesicle coat 42 24 4.45 + 7.57E-11 
heterotrimeric G-
protein complex 
43 24 4.55 + 1.21E-10 
cytoplasm 146 46 15.46 + 2.13E-10 
tubulin complex 25 18 2.65 + 4.99E-10 
MHC protein 
complex 
58 25 6.14 + 8.55E-09 
proton-transporting 
ATP synthase 
complex 
20 13 2.12 + 3.83E-07 
microtubule 348 61 36.86 + 1.46E-04 
extracellular region 505 31 53.49 - 5.36E-04 
extracellular matrix 501 31 53.07 - 6.49E-04 
cell junction 121 4 12.82 - 4.19E-03 
SNARE complex 38 10 4.03 + 8.40E-03 
organelle 94 18 9.96 + 1.35E-02 
mitochondrion 91 17 9.64 + 1.98E-02 
tight junction 34 0 3.6 - 2.72E-02 
plasma membrane 131 7 13.88 - 3.34E-02 
intermediate filament 
cytoskeleton 
130 21 13.77 + 4.11E-02 
gap junction 21 0 2.22 - 1.08E-01 
endoplasmic 
reticulum 
2 1 0.21 + 1.91E-01 
immunoglobulin 
complex 
32 4 3.39 + 4.39E-01 
cytosol 6 1 0.64 + 4.70E-01 
nucleus 23 2 2.44 - 5.60E-01 
chromosome 1 0 0.11 - 8.99E-01 
extracellular space 1 0 0.11 - 8.99E-01 
nuclear 
chromosome 
1 0 0.11 - 8.99E-01 
nucleolus 1 0 0.11 - 8.99E-01 
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Table 3 - Gene Ontology analysis of up-regulated proteins upon Hb-Hp exposure using 
PANTHER classification system. 
  
No. of proteins up-regulated 
in masterlist 
  
Biological 
Process 
masterlist 
REFLIST 
(2109) 
observed expected overrepresented P - value 
Blood circulation 23 9 0.62 + 1.22E-08 
Immune system 
response 
348 21 9.41 + 1.74E-04 
Cell adhesion 131 11 3.54 + 6.81E-04 
Response to 
external stimulus 
40 6 1.08 + 7.38E-04 
Blood 
coagulation 
40 6 1.08 + 7.38E-04 
Response to 
stimulus 
253 16 6.84 + 8.28E-04 
System process 245 15 6.62 + 1.75E-03 
Defense 
response to 
bacterium 
10 3 0.27 + 2.58E-03 
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Table 4 - Gene Ontology analysis of down-regulated proteins upon Hb-Hp exposure using 
PANTHER Classification system.  
  
No. of proteins down-
regulated in masterlist 
  
Biological 
Process 
masterlist 
REFLIST 
(2109) 
observed expected overrepresented P - value 
antigen 
processing and 
presentation of 
peptide or 
polysaccharide 
antigen via MHC 
class II 
18 10 0.39 + 6.32E-12 
antigen 
processing and 
presentation 
30 11 0.65 + 4.07E-11 
cellular defense 
response 
65 13 1.42 + 8.86E-10 
response to 
stimulus 
253 16 5.52 + 5.15E-05 
immune system 
process 
348 19 7.59 + 5.85E-05 
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Figure 1 – Experimental setup for the proteome analysis to monitor the effect of 
macrophages exposed to Hb-Hp. Human peripheral blood monocytes were incubated for 7 
days with purified Hb-Hp (1:1 molar ratio) complexes (2 mg/ml). At day 7 cells were lysed, 
the nuclei removed by centrifugation and the remaining cellular proteome was digested with 
trypsin. Following that, control cells were labelled with iTRAQ 114 resp. iTRAQ 116, Hb-Hp 
treated cells were labeled with iTRAQ 115 resp. iTRAQ 117. Labeled peptides were 
combined and fractionated by SCX-chromatographie with subsequent MALDI-TOFTOF and 
LTQ-Orbitrap analysis. Three independent experiments were performed. 
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Figure 2 – PANTHER gene ontology compartment classification of the identified 
macrophage proteome vs the whole human genome. 2109 protein ID’s (identifier: gene 
symbol) were classified according to their compartment localization. The complete list of 
cellular component classification is shown in Table 2.   
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Figure 3 - Theoretical estimated false discovery rate (FDR) is mapped to the protein 
score (x-axis) of all identified proteins by (A) MALDI-TOFTOF and (B) LTQ-Orbitrap. 
The function cfun(x) = a*exp(b*x) + c*exp(d*x) (red line) was fitted to the data curve by 
MATLAB. The red dotted line indicates the FDR threshold at 5%. All identifications with a 
FDR < 5% were accepted (minimum two unique peptides).   
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Figure 4 - Global view at pooled proteins from 3 healthy donors identified by either (A) 
MALDI-TOFTOF MS (n=2203) or (B) LTQ-Orbitrap MS (n=2858) sorted by their medians. 
Total identified proteins from both platforms were shown in (C). Red crosses indicate 
significant up- or down-regulated proteins by Hb-Hp (2 mg/ml) treatment (p < 0.005), black 
crosses indicate unchanged proteins. Red dotted line illustrates the 1.5-fold Standard 
deviation threshold. (D) illustrates the correlation of significant regulated (p < 0.005) proteins 
(n=99) identified in both MALDI-TOF and LTQ Orbitrap. The normalized median values for 
each protein and the linear fit are shown. Only proteins with a FDR < 5% are included. 
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Figure 5 – Volcano-plot of all identified proteins (n=3692). Red dots (n=205) indicate 
proteins that met our criteria of displaying > 1.5-fold changes (bordered by dashed line) with 
p < 0.005 (bordered by dash-dot line). These proteins were further selected for PANTHER 
classification analyses. 
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Figure 6 - Top 50 up-regulated proteins identified by MS measurements (p < 0.005). 
Right boxes represent Hb-Hp vs control normalized log(10) ratios of identified proteins with 
both techniques (red), only with MALDI-TOFTOF MS (black), or only with LTQ-Orbitrap MS 
(grey). Left boxes indicate control vs control normalized log(10) ratios of each identified 
protein. The interquartile range (25-75%), whiskers and median are shown for each protein. 
Protein names are indicated on the right y-axis; bold text highlights proteins characteristic in 
Hb polarized macrophages; accession numbers are shown on the left y-axis. 
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Figure 7 - Top 50 down-regulated proteins identified by MS measurements (p < 0.005). 
Left boxes represent Hb-Hp vs control normalized log(10) of identified proteins with both 
techniques (red), only with MALDI-TOFTOF MS (black), or only with LTQ-Orbitrap MS (grey). 
Right boxes indicate control vs control normalized log(10) ratios of each identified protein. 
The interquartile range (25-75%), whisker and median is shown for each protein. Protein 
names are indicated on the right y-axis, bold text highlights HLA class 2 proteins, accession 
numbers are shown on the left y-axis. Note the dominant and highly polymorphic HLA-DR 
molecules. 
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Figure 8 – Individual log (10) ratios of peptides identifying protein HLA-DRB1 
(accession # P20039) or HLA-DPB1 (accession # Q5SQ73). 116/114 is indicating the 
control vs control ratio while 115/114, 117/114, 115/116 and 117/116 represent Hb-Hp vs 
control ratios. Blue lines refer to peptides identified in macrophages of Donor 1, red lines 
refer to peptides of Donor 2 macrophages and black lines refer to the ones of Donor 3.  
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Figure 9 – HLA class 1 and 2 mRNA ratios and significantly (p < 0.005) down-regulated 
HLA class 2 proteins. Boxplots for each mRNA or protein ratio including median (red line) 
and outliers (red crosses) are shown. RNA ratios of HLA class 2 and HLA class 1 genes 
extracted at days 2 and 5 of incubation with Hb-Hp (2 mg/ml) are shown in (A). All quantified 
HLA-II proteins after 7 days of incubation with Hb-Hp (2 mg/ml) are illustrated in (B). 116/114 
indicate the control vs control ratio, while 115/114, 117/114, 115/116 and 117/116 refer to 
Hb-Hp vs control ratios (x-axis). Transcriptomic and proteomic data derive from three 
independent gene array and three iTRAQ experiments. 
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Figure 10 - Flow cytometric analyses of HLA-DR, CD86, CD14 and CD163 expression of 
human PBMC derived monocytes from buffy coats incubated with Hb-Hp (2 mg/ml) or 
untreated for 7 days. Data represent mean fluorescence intensity normalized to an isotype 
control for at least three independent experiments. The raw FACS data are given in the 
supplement (Figure S1 – S3) of this chapter * p < 0.05 
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A      B 
 
Figure 11 - Anti-oxidant and anti-inflammatory response of monocytes towards Hb-Hp 
exposure. (A) Intracellular reduced glutathione (GSH) of PBMC derived monocytes was 
measured after 5 days of incubation with highly purified Hb-Hp (2 mg/ml). GSH was 
quantified by applying a GSH standard curve. (B) Viability was measured relative to control 
cultures (100%) at day 7 after start of culture and incubation with Hb-Hp (2 mg/ml). Values 
represent means ± SEM of at least three independent experiments. *** p < 0.0005
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3.5. Supplement 
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Figure S1 – Flow cytometric analysis of indicated cell surface markers of human macrophages after 7 days of Hb-Hp (2 mg/ml) exposure 
or untreated control macrophages. Shown are raw data of one representative experiment. X-axis and y-axis represent fluorescence intensity of 
indicated markers.  
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Figure S2 – Flow cytometric analysis of indicated cell surface markers of human 
macrophages after 7 days of Hb-Hp (2 mg/ml) exposure or untreated control 
macrophages. Shown are histograms with geometric means. Red: isotype control, green: 
sample. X-axis represents fluorescence intensity of indicated markers.  
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Figure S3 – Flow cytometric analysis of indicated cell surface markers of human 
macrophages after 7 days of Hb-Hp (2 mg/ml) exposure or untreated control 
macrophages. Shown are histograms with geometric means. Red: isotype control, green: 
sample. X-axis represents fluorescence intensity of indicated markers.    
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4. Transcriptomic profiling of macrophages exposed to hemoglobin 
4.1. Abstract 
Tissue injury and hemolysis can initiate oxidative stress mediated by heme toxicity 
leading to inflammation. Macrophages display the unique ability to clear hemoglobin 
(Hb) and are therefore essential for wound healing. The cellular response of 
macrophages to heme involves the oxidative stress responsive transcription factor 
Nuclear Factor E2-related factor (Nrf-2) pathway resulting in the activation of 
antioxidant responsive element (ARE) – containing genes. To investigate the 
response of macrophages towards Hb-Hp complexes we applied global 
transcriptomic and proteomic strategies and found IL-8 to be the most induced gene. 
We could show that IL-8 expression correlates with Nrf-2 activation and confirmed 
the up-regulation of a characteristic set of anti-oxidant genes. In contrast, we could 
proof the absence of NF-ĸB-driven pro-inflammatory mediators such as TNF-α and 
IL-1β. Pre-treatment of macrophages with the glucocorticoid dexamethasone 
followed by Hb-Hp exposure resulted in significant IL-8 induction supporting a new 
role for IL-8 apart from its pro-inflammatory actions. Furthermore, we detected a link 
between enhanced erythropoiesis and increased oxidative stress by the highly 
induced kit ligand suggesting an induced “stress-erythropoiesis” upon increased 
heme availability. In summary, our data suggest a highly specialized macrophage 
subset with benefits in hemolysis, wound healing and inflammation. 
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4.2. Introduction 
Release of free Hb in case of red blood cell (RBC) destruction or hemolysis is critical 
due to the toxic nature of free Hb that can easily act as a peroxidase in the presence 
of superoxide radicals generated by inflammatory cells with very high oxidizing 
potential 1-2. Immediate binding of Hb to circulating acute phase plasma protein 
Haptoglobin (Hp) reduces Hb induced oxidative stress by preventing oxidation of Hb 
3-4. Macrophages exhibit the unique characteristic of expressing the scavenger 
receptor CD163 on their surface that is the only known receptor for Hb-Hp and Hb 
binding and removal by subsequent internalization and recycling 5-6. The cellular 
response of macrophages to this highly reactive heme stimulus results in the 
significant activation of detoxifying genes that are regulated by the conserved 
oxidative response transcription factor Nuclear Factor E2-related factor (Nrf-2). The 
antioxidant response element (ARE) is a DNA element located at the regulatory 
regions of phase II detoxification enzymes and proteins, such as heme oxygenase 1 
(HO-1), glutathione-S-transferases (GST), NAD(P)H:quinone oxidoreductase-1 
(NQO1) and ferritin, that contribute to the cellular antioxidant defense systems 7-8.  
 
In pathologic conditions, such as hemolysis, atherosclerosis, infection, inflammation 
and wound healing tissue macrophages play a crucial role. Not only by removal of 
Hb(-Hp) but also by recognizing and phagocytosing of potential pathogens they 
actively promote tissue repair mediated by the release of bioactive compounds that 
stimulate cell proliferation and attract more leukocytes to the damaged tissue 9. Due 
to their huge spectrum of activity, macrophages exhibit several sub-populations. A 
recent study suggests a new grouping of macrophage populations based on three 
homeostatic activities – host defense, wound healing and immune regulation 10.  
 
We discovered significant characteristics of the macrophage phenotype polarization 
cultured in Hb-rich environment to mimic conditions within wounded tissues and 
atherosclerotic plaques. The long-term effect of Hb resulted in significant suppression 
of HLA class 2 molecules most likely in order to reduce self-antigen presentation. We 
investigated the genome of macrophages differentiated under the influence of Hb-Hp. 
Applying whole genome arrays we found that Hb-Hp-treated macrophages are 
characterized by remarkable expression and secretion of high amounts of IL-8 with a 
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complete lack of pro-inflammatory mediators, such as IL-1β, TNF-α and IL-6. 
Interestingly, those macrophages did not express the anti-inflammatory cytokine IL-
10 that was reported to be produced upon Hb-Hp stimulation before 11. 
4.3. Methods 
4.3.1. Cell culture and experimental conditions 
Human monocytes were prepared from buffy coats of healthy blood donors 
(Blutspendedienst, Schlieren, Switzerland) by a strictly standardised protocol. Briefly, 
after Ficoll gradient separation (Ficoll-PaqueTM PLUS, Amersham Biosciences) and 
three washes with Mg2+/Ca2+ -free phosphate buffered saline (PBS; GIBCO Europe), 
cells were suspended in Iscove‟s modified Dulbecco‟s medium (IMDM; GIBCO 
Europe) supplemented with 10% heat-inactivated pooled human serum (complete 
medium) to prevent activation and seeded at a density of 107 cells/ml in 6-well tissue 
culture plates (Falcon Oxnard, USA). During 2 h under standard cell culture 
conditions (37°C, 5% CO2) in a SteriCult tissue culture incubator (Fisher Scientific, 
USA) monocytes adhered to the tissue culture plates. Afterwards, the cells were 
washed 3-4 times with Gey‟s balanced salt solution (Sigma) to remove nonadherent 
cells and the remaining monocytes were stimulated with 2 mg/ml Hb/Hp or Hb. 
Endotoxin free Hb was obtained from Hemosol (Ontario, Canada). Hp (mixed 
phenotype) was from Sigma (Buchs, Switzerland). Monocytes derived macrophages 
were kept in complete medium for 2 days respective 5 days for mRNA expression 
analysis using RT-PCR and Agilent whole genome 4 x 44 K arrays. For protein 
expression analysis culture time was prolonged to 7 days. 
For glucocorticoid priming, monocytes were incubated for 36 h with dexamethasone 
(Sigma) at a concentration of 2.5 × 10-7 M. After this priming period, 500 μg/ml 
purified Hb-Hp (1:1 molar ratio) was added. Following incubation for an additional 0, 
8, or 18 h, RNA was extracted and samples were analyzed with Agilent whole 
genome 44K arrays using a competitive two-color hybridization protocol. 
4.3.2. Reverse Transcription and Quantitative Real Time (RT)-PCR 
Total RNA was purified with the RNeasy mini kit according to the manufacturer‟s 
instructions (Qiagen, Basel, Switzerland). The method is based on the originally 
designed procedure of Chomczynski & Sacchi 12. RNA used for microarray analysis 
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was treated with a DNase I digestion step (Qiagen). RNA was quantified 
spectrophotometrically using Nanodrop ND-1000 spectrophotometer (NanoDrop 
Technologies, USA). Taqman RT-PCR reagents (Applied Biosystems, Life 
Technologies Corp., USA) were used for the generation of cDNA for all samples on a 
Mastercycler gradient (Vaudaux-Eppendorf, Schoenenbuch, Schwitzerland). cDNA 
samples were amplified using SYBR Green master mix reagent (Applied Biosystems) 
and sequence-specific primer pairs with a 7500 Fast Real-Time PCR System 
(Applied Biosystems). Melting curve analysis was performed after each PCR 
experiment to control for specificity of amplification reactions and to exclude 
excessive primer-dimer formation. Temperature cycling profiles were as follows: 10 
min at 95°C, 45 cycles of 15 sec at 95°C, 10 sec at 67–55°C, and 13 sec at 72°C. 
Gene specific quantitative data were normalized for Hypoxanthine 
phosphoribosyltransferase (HPRT) RNA abundance in the respective sample and are 
expressed as fold-expression in relation to the non-treated control. Primers were 
carefully designed to give a product of 150–200 bp using OligoPerfect™ Designer 
(Invitrogen) and were synthesized by Microsynth Laboratory (Balgach, Schweiz) (see 
Table 1).  
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 4.3.3. Quantification of secreted proteins 
The inflammatory cytokine TNF-α was quantified in undiluted supernatants of 
monocytes collected 30 min, 2 h, 4 h, 6 h, 24 h and 48 h after applying the stimulus 
(Hb-Hp 2 mg/ml). IL-8 was quantified in supernatants of monocytes collected after  
4 h, 24 h, 48 h and 5 days of exposure to Hb-Hp. IL-1β was measured in undiluted 
supernatants of Hb-Hp treated monocytes after 12 h, 48 h, 3 days and 4 days of 
incubation. For IL-8 measurements supernatants were diluted 1:1000 in complete 
medium. Each cytokine was measured individually using Bio-Plex Pro Magnetic 
Human Cytokine SinglePlex assays on the Bio-Plex 100 platform according to the 
manufacturer‟s instructions (Bio-Rad, USA). Complete medium was used as blank for 
supernatant measurements. Data were analyzed on the Bio-Plex fluorescence reader 
using Bio-Plex Manager software 4.1.1. (Bio-Rad). 
4.3.4. Isolation of globin from heme 
Human hemoglobin was diluted in phosphate buffer (100mM, pH 7.4) to a final 
concentration of 10 mg/ml, acidified to a pH of 1-2 using 37% HCl (Merck) and 
extracted with butanone (Sigma). The heme-containing butanone layer was 
separated from the globin-containing aqueous layer by centrifugation (16‟000 x g for 
10 min) and cleaned-up using PD-10 Desalting columns (GE Healthcare). Thus, the 
eluted globin-containing solution was sterile filtered for monocyte stimulation. 
4.3.5. Western blot analysis 
Monocytes grown on 6-well tissue culture plates were harvested using 300 µl/well 
CelLytic-M reagent (Sigma) supplemented with Complete Mini Protease Inhibitor 
(Roche Diagnostics). Lysate supernatant was separated by SDS/PAGE with 20 ug 
total protein load using a 4-15% gradient Tris-HCl gel (Criterion, Bio-Rad) and 
transferred to a nitrocellulose membrane (Amersham Biosciences, USA) using a wet 
transfer apparatus (Bio-Rad Power Pac). After blocking of unspecific binding sites, 
membranes were incubated with the specific antibody (Table 2) in PBS /0.1% Tween 
20 /10% goat serum resp. 5% milk (GIBCO, Europe) for at least 1 h at room 
temperature and probed with horseradish peroxidase-conjugated anti-rabbit IgG 
(resp. anti-goat IgG) (Amersham Biosciences) at a dilution of 1:10‟000. Bands were 
visualized using Amersham ECL detection kit according to manufacturer's 
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instructions and analyzed on a Chemi Doc XRS system with Quantity One 1-D 
Analysis software (Bio-Rad). 
4.3.6. Nuclear extracts 
Nuclear extracts were prepared using a nuclear extract kit (Active Motif, USA) 
according to the manufacturer‟s protocol. Monocytes grown on 12-well tissue culture 
dishes for 4, 24 and 48 h were washed and collected by scraping with ice-cold PBS 
in the presence of phosphatase inhibitors. After centrifugation, cells were 
resuspended in hypotonic buffer and treated with detergent to promote the leakage of 
cytoplasmic fraction into the supernatant. The remaining nuclear proteins were 
solubilized in lysis buffer containing a protease inhibitor cocktail. To determine the 
protein concentration of the nuclear fractions, samples were diluted 1:100 in reaction 
buffer (Invitrogen) and measured in a QubitTM Quantitation reader (Invitrogen). 
4.3.7. Transcription factor analysis 
Nuclear extracts of monocytes were prepared as described. Nuclear Nrf-2 or NF-ĸB 
p65 binding activity was determined by using TransAM transcriptional factor assaying 
kits according to the manufacturer‟s instructions (Active Motif, USA). This is an 
ELISA-based quantitative assay of Nrf-2 or NF-ĸB p65 binding activity using 
antibodies directed against Nrf-2 or NF-ĸB p65 subunit. 
4.3.8. Gene array experiments 
Gene expression profiling was performed by competitive dual-color hybridization of 
complementary RNA probes of treated and untreated cells on human 4 x 44 K 60-
meroligonucleotide microarray chips (Agilent Technologies, USA) according to 
manufacturer‟s instructions. For quality control and to quantify samples, each purified 
RNA sample (1 μl) was analyzed on RNA 6000 Nanochip (Bioanalyzer 2100 
instrument, 2100 Expert software, Agilent Technologies). High quality total RNA had 
an 18/28 S ribosomal RNA ratio > 1.5. Total RNA was frozen in aliquots at -80°C. 
cRNA probes were then synthesized from 200ng aliquots of total RNA using low 
input fluorescence linear amplification kit protocol and spiked with control targets 
(Agilent Technologies). Cyanine-3-dCTP (Cy3, control cells) or cyanine-5-dCTP 
(Cy5, treated cells) labeled cRNA probes were purified on RNAeasy mini spin 
columns (Qiagen) and spectrophotometrically quantified (NanoDrop Technologies, 
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USA). Equal quantities of Cy3- and Cy5-labeled probes (825 μg each) were mixed 
and incubated in fragmentation buffer in the dark for 30 min at 60°C. After 
fragmentation, control and respective treatment samples were hybridized on whole 
human genome (4 x 44 K) oligonucleotide microarrays (Agilent Technologies) for 17 
h at 65°C in a hybridization oven (Agilent Technologies) under rotation of 10 rpm. 
After washing twice in GE washing buffer (Agilent Technologies) for 1 min, 
microarray slides were carefully placed in acetonitrile (ACN) for 30 sec and dried. 
Slides were scanned using a dual-laser microarray scanner and analyzed with 
Feature Extraction software (Agilent Technologies). Data mining was achieved using 
the Rosetta Resolver Gene Expression Data Analysis System Version 7.2 (Rosetta 
Biosoftware, USA). Further data analysis was performed using Matlab 7.9 (The 
MathWorks Inc., Bern, Switzerland). Genes regulated ≥ 1.5 fold were set as 
specifically regulated. Functional clustering of regulated genes was investigated 
using GeneGo Metacore software (GeneGo, USA).  
4.3.9. Sample treatment for iTRAQ analyses  
Human-blood derived monocytes were prepared from 3 healthy donors, as described 
before and cultured in IMDM (GIBCO, Europe), supplemented with 10% heat-
inactivated, pooled human serum from 8 healthy donors. For each tested condition 
(media alone or 2 mg/ml Hb-Hp) samples were prepared in 3 biological replicates as 
mentioned above, whereas each replicate was divided into two portions for 
experimental replicates. At day 7 of culture total cellular protein was extracted from 
human-blood derived macrophages, grown in 24-well plates. Supernatant was 
removed and cells were harvested by scraping using 100 µl CelLytic-M reagent 
(Sigma) supplemented with Complete Mini Protease Inhibitor (Roche Diagnostics). 
After three freeze-thaw cycles and sonication with a Branson Sonifier 250, cellular 
debris was removed by centrifugation at 16‟000 x g for 10 min. Protein concentration 
of each sample was determined using a protein Bradford assay (Bio-Rad, USA). 
Samples normalized to 60 µg of protein were precipitated by adding 1 volume of 
trichloroacetic acid (TCA) to 4 volumes of protein solution to a final concentration of 
10-12% w/v TCA and incubated at 4°C for 10 min. After centrifugation at 16‟000 x g 
supernatant was removed, pellets were washed three times with ice-cold acetone 
and dried in a heat block at 95°C for 10 min.  
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4.3.10. iTRAQ labeling 
Pellets were reconstituted in 20 µl of dissolution buffer and 1 µl of denaturant 
according to the protocol of the iTRAQ manufacturer (Applied Biosystems, USA). 
Additionally, we added 4 µl of 6 M freshly prepared urea to the pellets. Disulfide 
bonds were reduced by adding 2 µl of reducing agent and blocked by treatment with 
1 µl of cysteine blocking reagent. A total of 60 µg of protein was digested overnight at 
37°C with trypsin (Promega, USA) in the ratio 1:10, trypsin to protein. Peptides were 
covalently modified for two hours with an isobaric tag reagent according to the 
following scheme: iTRAQ 114 (control macrophages), iTRAQ 115 (Hb-Hp treated 
macrophages), iTRAQ 116 (control macrophages) and iTRAQ 117 (Hb-Hp treated 
macrophages). After combining the iTRAQ reagent labeled peptides, the reaction 
was stopped by adding 10 µl of phosphoric acid (pH 2-3).  
4.3.11. SCX fractionation 
The labeled peptides were fractionated by strong cation exchange liquid 
chromatography (SCX) using a Polysulfoethyl A 2.1 mm x 200 mm, 5 µm, 300 Å 
column (PolyLC, USA). Solvent A was 10 mM potassium phosphate, 25% acetonitrile 
(ACN), pH 2.7, and solvent B was 10 mM potassium phosphate, 350 mM potassium 
chloride, 25% ACN, pH 2.7. The iTRAQ labeled peptides were diluted in a ratio 1:4 in 
solvent A and applied to the SCX column. Chromatography was performed at a flow 
rate of 0.3 ml/min according to the following gradient: 0-10 min 0% solvent B; 10-60 
min 0-100% solvent B; 60-65 min 100% solvent B; 65-90 min 0-100% solvent A. For 
each HPLC run, 24 out of 27 fractions were collected and partially evaporated to 
remove ACN in a vacuum concentrator. The collected fractions were re-dissolved in 
5% ACN, 0.1% trifluoroacetic acid (TFA), combined to 8 pools (each pool contained 3 
fractions) and desalted with Sep Pak C18 cartridges (Waters, USA). The 8 labeled 
sample pools were dried in a vacuum concentrator and reconstituted in 10 µl of 3% 
(v/v) ACN /0.2% formic acid. 5 µl of each pool was transferred to a new tube and 
combined to 4 sample pools for MALDI-TOFTOF MS analyses.  
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4.3.12. Nano-LC separation and MALDI target plate spotting of tryptic peptides 
Peptide separation was performed on an Ultimate chromatography system (Dionex - 
LC Packings, USA) equipped with a Probot MALDI spotting device. A volume of 5 µl 
of each sample was injected by using a Famos autosampler (Dionex - LC Packings) 
and loaded directly onto a 75 µm x 150 mm reversed-phase column (PepMap 100, 3 
m; Dionex - LC Packings). Peptides were eluted at a flow rate of 300 nl/min by 
using the following gradient: 0-10 min, 0% solvent B; 10-105 min, 0-50% solvent B; 
and 105-115 min, 50-100% solvent B. Solvent A contained 0.1% TFA in 95:5 
water/ACN , and solvent B contained 0.1% TFA in 20:80 water/ACN . For MALDI 
analysis, the column effluent was directly mixed with MALDI matrix solution (3 mg/ml 
-cyano-4-hydroxycinnamic acid in 70 % (ACN /0.1 % TFA) at a flow rate of 1.1 
µl/min via a µ-Tee fitting. The matrix solution also contained neurotensin at a 
concentration of 125 pmol/ml (Sigma, USA) for internal calibration. Fractions were 
automatically deposited every 10 s onto a MALDI target plate (Applied 
Biosystems/MDS Sciex, USA) using a Probot microfraction collector. A total of 416 
spots were collected from each HPLC run. 
4.3.13. MALDI-TOFTOF mass spectrometry  
MALDI plates were analyzed on a 4800 MALDI-TOFTOF system (Applied 
Biosystems) equipped with a Nd:YAG laser operating at 200 Hz. All mass spectra 
were acquired in positive reflector mode and generated by accumulating data from 
800 laser shots. First, MS spectra were recorded from peptide standards, and the 
default calibration parameters were updated. Second, MS spectra were recorded for 
all sample spots on the MALDI target plate (416 spots per sample, 4 samples per 
plate). The MS spectra were recalibrated internally based on the ion signal of 
neurotensin peptide (Sigma).  
The following threshold criteria and settings were used for the acquisition of MS/MS 
spectra: Mass range: 800 to 4000 Da; minimum signal-to-noise (S/N) for MS/MS 
acquisition: 100; maximum number of peaks/spot: 8. Peptide CID was performed at a 
collision energy of 1 kV and a collision gas pressure of approximately 2.5 x 10-6 Torr. 
During MS/MS data acquisition, a method with a stop condition was used. In this 
method, a minimum of 1000 shots (20 sub-spectra accumulated from 50 laser shots 
each) and a maximum of 2000 shots (40 sub-spectra) were allowed for each 
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spectrum. The accumulation of additional laser shots was halted whenever at least 6 
ion signals with an S/N of at least 60 were present in the accumulated MS/MS 
spectrum, in the region above m/z 200. 
4.3.14. Peptide and protein identification and quantification by database searching 
Raw spectra were processed with Mascot Distiller 2.2 (Matrix Science, London, UK) 
and protein identification and quantitation was performed using Mascot Version 2.2.0 
(Matrix Science) as search engine. Mascot generic files were searched against a 
SwissProt human protein sequence database that was downloaded from 
ftp.ebi.ac.uk/pub/databases/SPproteomes (database release February 11, 2009; 
117865 protein sequences (with 56722 forward and reverse sequences, respectively, 
and 259 contaminant sequences). The following search parameters were used: 
trypsin digestion, maximum missed cleavages: 2; maximum number of signals per 
spectrum: 55, peptide mass tolerance: 25 ppm and fragment ion tolerance: 0.3 Da. 
Further, iTRAQ4plex reagent labeling of lysine and of the N-terminal amino group of 
peptides and methylmethanethiosulfate-labeled (MMTS) modifications of cysteine 
were specified as fixed modifications, oxidation on methionine as variable 
modification. For the quantitation of iTRAQ labeled peptides the isotopic correction 
factor was used as supplied by the manufacturer (Applied Biosystems). iTRAQ ratios 
of proteins were median normalized and protein ratios were determined as the 
geometric mean of the peptide ratios. False discovery rates (FDR) were estimated by 
searches against a corresponding database containing forward and reversed 
sequences, according to the method of Kall (as described in chapter 3). Further 
analysis of proteomics data were performed using MATLAB 7.7.0. software (The 
MathWorks Inc., Bern, Switzerland). 
4.4. Results 
4.4.1. Differential gene expression in Hb-Hp treated macrophages 
We performed gene array experiments of human peripheral blood monocyte-derived 
macrophages exposed for 2 and 5 days to Hb-Hp (2 mg/ml). Transcriptional profiles 
of identical experimental settings from three independent donors were analysed with 
Rosetta Biosoftware. After 2 days 451 genes were regulated ≥ 1.5-fold (p ≤ 0.01) in 
these macrophages. Of the 451 genes significantly affected by 2 days of Hb-Hp 
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incubation, 153 were also significantly regulated after 5 days of Hb-Hp exposure (see 
supplemental data). Additionally, 775 genes affected by Hb-Hp treatment after 5 days 
were detected (Figure 1). We assumed the 153 consistently regulated genes at both 
time points to be of biological significance and investigated them further. First, we 
applied a correlation analysis of genes commonly regulated at both time points. 
Thus, we determined which functional categories are over-represented among the 
up-regulated genes with a given statistical significance (p < 0.01; fold change > 1.5) 
using Metacore software. Genes were classified according to Metacore biological 
processes and in particular, significantly up-regulated genes were over-represented 
in categories related to cell adhesion, chemotaxis and responses to oxidative stress. 
Further, we found genes over-represented in the blood coagulation process and iron 
transport (Figure 2). The complete set of genes is accessible at 
www.ebi.ac.uk/aerep/login (reviewer account login: Reviewer_E-MEXP-2820; 
Password: 1279719286410).  
4.4.2. Confirmation of the microarray results by RT-PCR and western blot 
In order to confirm the transcriptional expression pattern obtained from the 
microarray analysis we performed RT-PCR of selected genes related to chemotaxis 
(IL-8), anti-oxidative response (HO-1, SLC7A11), blood coagulation (PAI-2) and iron 
(heme) transport (ABCB6). Further, we chose to confirm the increased expression of 
the cholesterol transporter ABCG1 and the erythropoiesis stimulating kit ligand 
(KITLG) (Figure 3). The regulation of IL-8 (Figure 4B), HO-1, PAI-2 and xCT but 
also CD163 (data not shown) was confirmed at the protein level. Among the 
significantly regulated genes upon Hb-Hp exposure, we found that also 
NAD(P)H:quinone oxidoreductase (NQO1) and malic enzyme (ME1) contribute to the 
group of anti-oxidative genes. 
4.4.3. Consistent IL-8 secretion drives leukocyte chemotaxis to injured tissue 
IL-8, a cytokine with a recently detected NRF2 binding locus, was consistently 
enhanced by Hb-Hp treatment, both at 2 and 5 days. First, we investigated the 
secretion of IL-8 by Bio-Plex analysis in the macrophage supernatant at several time 
points after Hb-Hp treatment (Figure 4A). At the earliest time point at 4 h, we could 
not observe any induced IL-8 secretion compared to untreated cells. With increasing 
time, at 24 h we detected a moderate but already significantly enhanced IL-8 
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secretion upon Hb-Hp stimulation. After 5 days of Hb-Hp exposure we observed a 
massive IL-8 secretion (up to 80 ng/ml). Figure 4B illustrates quantitative 
assessment of IL-8 within and outside the cell. At day 7 and 10 the major part of IL-8 
was already secreted and not sequestered within the cell. In order to confirm the 
heme group being responsible for the IL-8 induction we isolated globin from 
hemoglobin and monitored IL-8 secretion using different concentrations of Hb-Hp and 
globin. Figure 4C shows that only a concentration of 2 mg/ml Hb-Hp causes a 
significant IL-8 secretion while globin failed to induce release of significant amounts 
of IL-8 at 2 mg/ml. Based on these findings we could justify the application of 
relatively high amounts of Hb-Hp and proof the activation of IL-8 most probably 
independent of the globin group. Since IL-8 under Hb-Hp exposure might be 
activated by Nrf-2 we investigated the activity of this transcription factor and 
observed an increasing activation with time (Figure 4D). We assume that Hb-driven 
Nrf-2 activation leads to selective IL-8 secretion and enhanced leukocyte influx to the 
damaged tissue sites. 
4.4.4. Hb-Hp exposed macrophages display an augmented Nrf-2 activation and 
selectively secrete IL-8  
To further proof the exclusive role of IL-8 in a simulated wound scenario by exposure 
to high amounts of Hb-Hp we investigated the transcriptional expression and 
subsequent secretion of nuclear factor - ĸB (NF-ĸB) driven cytokines such as IL-1β, 
TNF-α and IL-6 as shown in Figure 5. After 2 days of Hb-Hp treatment neither IL-6 
(A) nor IL-1β (B) was increased at mRNA level. IL-1β was not secreted either (D). 
We monitored TNF-α levels starting at 30 min after Hb-Hp exposure up to 48h and 
could not observe any secretion. In contrast, monocytes stimulated with 100 ng/ml 
LPS showed an early secretion of TNF-α (C) with reaching a maximum at 4 h 
(~10ng/ml) as expected. Consequently, we did not observe any NF-ĸB (p65) 
activation (data not shown) in macrophages exposed to Hb-Hp compared to control 
cells.  
We also monitored the effects of dexamethasone, a glucocorticoid for treatment of 
autoimmune hemolytic anemia, on macrophages. Using gene array analysis we 
observed that glucocorticoid priming (36h, 2.5x10-7M) and subsequent Hb-Hp 
exposure (8-16 h, 500 µg/ml) shifts the monocte differentiation towards a phenotype 
with highly efficient Hb clearance as shown in Figure 6. Moreover, these 
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macrophages showed a higher induction of IL-8 (fold change of 7.5) compared to 
macrophages exposed to glucocorticoid alone. Macrophages only treated with Hb-Hp 
for 8-16 h showed a moderate induction of IL-8 (fold change of 3.0). We observed an 
even higher expression of IL-8 in macrophages exposed to Hb-Hp (2 mg/ml) for 2 
days (fold change of 10.6) or 5 days (fold change of 4.6) (data not shown). We 
conclude that glucocorticoid treatment could stimulate the monocyte anti-oxidant 
pathways during hemolysis.  
4.4.5. Correlation analysis of macrophage transcriptome and proteome after Hb-Hp 
exposure 
We recently investigated the composition of the macrophage proteome after long-
term Hb-Hp using state-of-the-art proteome approaches (see chapter 3). As we could 
demonstrate, many proteins were significantly affected by Hb-Hp leading to the 
development of a characteristic anti-oxidative, Hb-clearing phenotype with decreased 
immune activating capacity by mainly reduced HLA class 2 expression. It seems 
obvious to compare the transcriptional profile of these macrophages at day 2 and 5 
with the proteome of macrophages exposed to Hb-Hp for 7 days. To investigate how 
mRNA expression levels matched to protein expression levels we applied correlation 
analysis of the genes and proteins that exhibited a p-value less than 0.01 (Figure 7). 
The correlation coefficient per se was expected to be suboptimal because of the 
large time interval between transcriptome and proteome analysis. Nevertheless, 
correlation analysis showed that HO-1 and PAI-2 were significantly induced at both 
mRNA and protein level.  
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Table 1 - Oligonucleotides used for detection of indicated genes with RT-PCR 
Primer 5’                                                3’ 5’                                              3’ 
HO-1 AGGGTGATAGAAGAGGCCAAGACT TTCCACCGGACAAAGTTCATGGC 
IL-8 AGACAGCAGAGCACACAAGC AGTGTTCCTTCCGGTGGT 
SLC7A11 GGCAGTGACCTTTTCTGAGC TCATTGTCAAAGGGTGCAAA 
ABCG1 CTGGTGAACAACCCTCCAGT ATCTGCTGGGTTGTGGTAGG 
PAI-2 GTTCATGCAGCAGATCCAGA CGCAGACTTCTCACCAAACA 
KitL ATTCAAGAGCCCAGAACCC CTGCTACTGCTGTCATTCC 
HPRT CCAGTCAACAAG CACAATCAAGAC 
 
Table 2 - Antibodies used for western blot analysis 
Antibody Organism Host Dilution Manufacturer 
IL-8 human rabbit 1:1000 Peprotech 
α-tubulin human mouse 1:5000 Abcam 
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Figure 1 - Genes consistently regulated in macrophages exposed to Hb-Hp. (A) Venn 
diagram of significantly regulated genes (p ≤ 0.01 and fold change ≥ 1.5) at day 2 and 5 after 
Hb-Hp exposure. A complete list of the 153 genes, including ratios and p values, is provided 
in Supplementary Table 1 - 6. (B) Correlation of significantly regulated genes (p ≤ 0.01 and 
fold change ≥ 1.5) 2 days and 5 days after Hb-Hp exposure. Red indicates genes with a p ≤ 
0.0001. (C) Illustration of the top 20 up-regulated genes (p ≤ 0.0001 and fold change ≥ 1.5). 
Red circles represent the means between the log(ratio) of day 2(x) and day 5(*). Primary 
sequence cluster name of selected genes are indicated at the left y-axis. Data represent 
three independent experiments. 
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Figure 2 – Functional clustering of genes up-regulated by Hb-Hp exposure. Genes 
showing a fold change of at least 1.5 at both time points, day 2 and day 5, were selected and 
characterized according to their GO biological process in the GeneGo Metacore software 
and compared to the classification of all present genes in the array in order to find which 
functional categories were over-represented (p < 0.01).  
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Figure 3 – RNA changes of selected genes responsive to Hb-Hp. Induction of mRNA 
levels of selected target genes after incubation with either Hb-Hp or Hb (2 mg/ml each) for 2 
days (grey bars) respective 5 days (black bars). Data represent means ± SEM from at least 
three independent measurements. 
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Figure 4 – Macrophages exposed to Hb-Hp display an augmented Nrf-2 activation and 
selectively secrete IL-8. (A) IL-8 secretion upon Hb-Hp exposure (2 mg/ml) at different time 
points using Bio-Plex human cytokine singleplex assay. (B) Confirmation of secreted IL-8 in 
lysates and supernatants of Hb-Hp or Hb (2 mg/ml each) treated macrophages after 7 days 
respective 10 days. SN = supernatant. (C) Measurement of IL-8 in Hb-Hp or globin treated 
macrophage supernatant at different concentrations after 2 days using Bio-Plex human 
cytokine singleplex assay. (D) Nrf2 activity (OD450) in nuclear extracts of macrophages 
measured after incubation with Hb-Hp (2 mg/ml) at several time points. Data are means ± 
SEM from at least three independent measurements. 
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Figure 5 – Confirmation of the non-inflammatory response of Hb-Hp exposed 
macrophages. Measurement of mRNA levels of IL-6 (A) and IL-1β (B) after 2 days of 
incubation with Hb-Hp or Hb (2 mg/ml each). (C) TNF-α secretion in supernatants of 
macrophages stimulated with Hb-Hp or LPS (100 ng/ml) measured at several time points as 
indicated. (D) IL-1β secretion in supernatants of macrophages exposed to Hb-Hp for 
indicated time points. Shown are means ± SEM from at least three independent 
measurements. 
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Figure 6 - Effects of the glucocorticoid dexamethasone and Hb-Hp on monocyte gene 
expression. The table shows 47 genes significantly co-regulated by dexamethasone priming 
and Hb-Hp exposure, and were induced >1.5-fold in dexamethasone-primed cells. The graph 
on the right shows the corresponding gene expression changes (log ratio; mean ± error, n=4) 
induced by Hb-Hp (500 µg/ml) in either dexamethasone (2.5x10-7 M) pre-treated (red) or non-
treated (black) monocytes. Note that almost all genes on this list exhibit greater induction or 
suppression in monocytes pre-treated with dexamethasone pathway.   
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A       B 
 
Figure 7 – Correlation analysis of the macrophage transcriptome and proteome. (A) 
Log(10) ratio of genes identified at day 2 correlated to their log(10) ratio of protein identified 
with MALDI-TOFTOF at day 7. (B) Log(10) ration of genes identified at day 5 correlated to 
their log(10) ratio of protein identified with MALDI-TOFTOF at day 7. Macrophages were 
exposed to 2 mg/ml Hb-Hp for indicated times. Red dots represent correlation of transcripts 
with their corresponding proteins, black dots indicate anti-correlation of genes and protein 
data, while grey dots represent no change in expression. (GCLC = Glutamate-cysteine 
ligase; GSR = Glutathione reductase; GSTM1 = Glutathione-S-transferase M1; FTH1 = 
Ferritin heavy chain; FTL = Ferritin light chain; SOD2 = Superoxide dismutase 2; SERPINB2 
= PAI-2 = Plasminogen activator inhibitor 2). Data represent mean of three independent 
experiments. 
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4.5. Discussion 
Macrophages display a huge variety in their phenotypes depending on the particular 
microenvironment in specific tissues. In case of tissue injury, they are known to be 
the most important mediators for wound healing which follows a predictable 
sequence of events 13-15. Nevertheless, adequate knowledge about this highly 
specialized macrophage phenotype is still missing. In the current study we could 
contribute to the understanding of macrophages involved in tissue repair by following 
findings: 1) Enhanced Hb uptake capacity by increased scavenger receptor CD163 
expression with subsequent HO-1 induction and anti-oxidant homeostasis after 
administration of excess Hb-Hp. 2) Selectively stimulated secretion of the leukocyte 
chemo-attractant IL-8 and inhibited pro-inflammatory activity indicating a protective 
and non-inflammatory phenotype with the ability to recruit other cells to the site of 
injury. 
 
Gene arrays provide a powerful tool to explore the differences among expression 
levels of less abundant but highly active genes, such as cytokines. We could show 
that macrophages respond to Hb-Hp with a specialized Hb-clearing, anti-oxidant, and 
tissue repair promoting pathway. Recently, we applied proteomic strategies to 
discover the complex macrophage proteome but also to investigate the most 
abundant regulated proteins affected by Hb-Hp treatment. To our surprise, these 
macrophages displayed a remarkable suppression of antigen presentation by HLA 
class 2 molecules. Further, these macrophages showed high levels of ferritin which 
contributes to the Hb degradating and iron recycling activity. To monitor the changes 
in gene expression and the consistently expression of biological most important 
regulated genes we focused on the macrophage genotype after 2 and 5 days of Hb-
Hp exposure. Nevertheless, a comparison between transcriptome and proteome 
could be expected to be rather complementary than correlative in the herein 
presented time frame. Correlation analysis returning a higher correlation coefficient is 
often due to more narrow time subsets allowing less space for post-translational 
modifications. 
 
Erythropoiesis is regulated by a number of growth factors, among which kit ligand 
plays a non-redundant function 16. Kit ligand has been claimed to cause proliferation 
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but not differentiation of hematopoietic cells 17-18 and has been reported to support 
the maintenance of primitive hematopoietic progenitor cells 18. Acute anemia induces 
a systemic response characterized by a rapid mobilization and differentiation of 
erythroid progenitors 19. In this case the expansion and differentiation of a specialized 
population of stress erythroid progenitors is known to play an important role during 
recovery from acute anemia. Kit ligand has been shown to greatly expand the 
progeny of these stress erythroid progenitors and led to the suggestion that kit 
ligand/kit signalling may play a role in stress-erythropioesis 20. Macrophages treated 
with Hb-Hp showed a high induction of kit ligand linking Hb- clearance of 
macrophages to enhanced erythropioesis during hemolysis putatively due to 
increased availability of recycled iron. Although we found high levels of kit ligand 
mRNA in macrophages exposed to Hb-Hp for 2 and 5 days we did not observe kit 
ligand in the macrophage proteome after 7 days of Hb-Hp treatment. We assume 
that there are yet unknown mediators that inhibit the translation of kit ligand mRNA 
into protein during iron homeostasis. Also, post-translational modifications (PTMs) 
might have an influence on the protein expression of kit ligand.  
 
The SLC7A11 gene that we found highly induced upon Hb-Hp exposure (Figure 1C 
and Figure 3), encodes the heterodimeric plasma membrane cystine/glutamate 
exchanger which mediates the entry of cystine into the cell by simultanous efflux of 
glutamate 21-22. Inside the cell, cystine is rapidly reduced to cysteine, the rate limiting 
substrate for the synthesis of reduced glutathione (GSH), that plays an important role 
in the cell‟s defense against oxidative stress 23. Treatment of macrophages with Hb-
Hp showed a high xCT mRNA level compared with untreated macrophages and led 
us to the assumption that this antiporter is an important marker during monocyte 
differentiation under Hb-Hp exposure. xCT-overexpressing cells become highly 
resistant to oxidative stress, particulary upon GSH depletion. Thus, the regulated 
expression of SLC7A11 contributes to the anti-oxidative activity of macrophages 
during hemolysis and tissue repair. Also, strong evidence for the anti-oxidative 
character of Hb-Hp exposed macrophages is the highly induced heme transporter 
ABCB6 that mediates heme-iron influx from the cytoplasm into the mitochondria and 
promotes mitochondrial metal homeostasis under oxidative stress 24. 
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Hb-Hp uptake by macrophages over the period of 2-7 days induced PAI-2 (also 
SERPINB2) mRNA and protein levels. PAI-2 is considered to be a stress protein and 
one of the most up-regulated proteins of activated macrophages 25-26. Further, it is 
proposed to exhibit roles in the regulation of inflammation and wound healing 26. 
Locally secreted PAI-2 in tissues could limit extracellular proteolysis during tissue 
remodelling, such as it appears during wound healing. These findings contribute to 
the defined macrophage phenotype. 
 
By analysing the list of transcripts that were enhanced by Hb-Hp treatment we 
detected an over-representation of genes regulated by the transcription factor Nrf-2 
that binds to the anti-oxidant response element (ARE). We could show that anti-
oxidant genes such as HO-1, NQO1 and GCLM are highly regulated by Nrf-2. In the 
present study we could show that the cytokine IL-8, which was recently found to 
exhibit an ARE binding site, is also likely to be regulated by Nrf-2. In particular, Nrf-2 
is suggested to increase the half-life of IL-8 mRNA. We monitored IL-8 secretion and 
found significant amounts of this cytokine in the supernatant of Hb-Hp treated 
macrophages. Following, we investigated Nrf-2 activation upon Hb-Hp treatment in 
these macrophages and found it to be significantly activated. To further investigate 
the selective activation of Nrf-2 we analysed levels of typical NF-ĸB driven pro-
inflammatory cytokines such as IL-1β, TNF-α and IL-6. As expected, we could not 
detect any induced expression of inflammatory cytokines and accordingly levels of 
NF-ĸB remained at the basal activity compared to control macrophages. It is known 
that a constitutive expression of NF-ĸB in monocyte-derived macrophages is 
essential to maintain mitochondrial homeostasis and increase cell survival 27. Further, 
HO-1 derived CO was reported to require NF-ĸB activity in order to protect against 
apoptosis of endothelial cells 28. 
 
HO-1 has been demonstrated to be a down-stream effector of IL-10 29 and Hb-Hp 
complexes in turn trigger the induction of IL-10 and HO-1 11. Interestingly, our Hb-Hp 
exposed macrophages lacked the expression of IL-10 but showed a high induction of 
anti-oxidative enzymes such as HO-1. We speculated that former observed IL-10 
induction upon Hb-Hp uptake was most probably due to endotoxin-contaminated Hb. 
Since we use purified endotoxin-free Hb in our experimental setup we could exclude 
any contaminations and accordingly LPS-induced IL-10 expression. Also, we found 
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GTP cyclohydrolase 1, an enzyme mediating the biosynthesis of neopterin derivates 
in human macrophages, to be significantly down-regulated upon Hb-Hp exposure. 
Neopterin levels in human body fluids serve as a common innate immune system 
and macrophage activation marker 30, and in turn suggest a deactivation of the 
macrophages in our experiments. These findings support our theory that Hb-Hp 
exposed macrophages develop a non-inflammatory phenotype highly dependent on 
the anti-oxidative effects of HO-1 and its by-products.  
 
A limitation of the study is the in vitro culture of pure macrophages cannot reflect the 
complex situation in wounded tissues. Nevertheless, we were interested in 
investigating the direct effect of Hb-Hp complexes in a standardised system of 
macrophages with the unique ability to clear and detoxify these complexes in a 
wound. Further studies could explore the impact of Hb-Hp polarized macrophages on 
other cell types such as T-cells, neutrophils and endothelial cells. 
 
In conclusion, Hb-Hp challenged macrophages displayed a protective geno- and 
phenotype shift characterized by enhanced anti-oxidative response linked to 
increased iron-homeostasis. Further, these macrophages did not express any pro-
inflammatory mediators in order to create a non-inflammatory milieu e.g. in wounds 
to promote tissue repair. Also, by selective release of IL-8 they could consult other 
leukocytes and flag the area of damage. The findings in the present study support 
the idea of a highly specialized Hb-Hp induced macrophage sub-population in 
hemolysis, wound healing or inflammation. Further, this phenotype switch could be 
supportingly induced by the application of glucocorticoids in the case of hemolysis. 
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4.6. Supplement 
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5. Conclusions and Outlook 
In diseases causing hemolysis massive amounts of free Hb are released into the 
circulation. Due to the toxic nature of Hb it is immediately captured by Hp and forms 
an irreversible complex. The only known receptor for the Hb-Hp complex is CD163, a 
member of the SRCR family, which is exclusively expressed on monocytes and 
tissue macrophages. By means of immunofluorescence and uptake assays, it could 
be shown that besides the critical SRCR domains 4-6, also the domain 8 plays a 
non-redundant role in Hb-Hp binding and uptake. Once internalized, the degradation 
of the Hb-Hp complex is mediated by HO-1 with subsequent release of anti-oxidant 
byproducts, namely CO, iron and bilirubin. 
A lot of attention has been paid to the Hb-induced HO-1 pathway within the 
macrophages. Nevertheless, the idea that Hb-Hp itself could generate a specific 
macrophage phenotype was not known yet. Macrophages display a huge diversity of 
phenotypes and capabilities depending in part on the signals from the immediate 
microenvironment. With means of comprehensive transcriptome and proteome 
profiling of Hb-Hp exposed macrophages a new and highly specified phenotype with 
a particular role in wound healing and an enhanced Hb-clearance and anti-oxidative 
capacity could be identified as summarized in the scheme. Intracellular degradation 
of Hb and heme activates the Nrf-2/ARE pathway with subsequent enhanced 
expression of antioxidative enzymes, such as HO-1 and NQO1. The main and newly 
identified characteristics of these Hb-Hp polarized macrophages are as follows: i) 
increased and selective expression and secretion of IL-8 in order to attract 
leukocytes to the injured tissue ii) complete lack of pro-inflammatory mediators such 
as TNF-α, IL-1β and IL-6 and iii) significant suppression of all detected HLA class 2 
molecules and co-stimulatory molecules, in particular CD86. To date, the exact 
mechanism leading to HLA class 2 suppression during extraordinary Hb-Hp exposure 
remains unknown. Nevertheless, it might arise from posttranslational modifications 
(PTMs) that are able to modify CIITA activity and genes encoding HLA class 2 
proteins. Additionally, it could be shown that pre-treatment of macrophages with 
glucocorticoids, such as dexamethasone, and subsequent exposure to Hb-Hp even 
intensified the anti-oxidative activity of this particular phenotype by increased Hb-Hp 
clearing and iron-recycling capacity. In conclusion, this work adds new important 
elements to the understanding of macrophages involved in Hb-Hp clearance and 
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catabolic detoxification such as in hemolysis and wound healing and might define 
new targets for therapeutic intervention in hemolytic diseases.   
 
Scheme – Illustration of the global changes in macrophages induced by Hb-Hp 
exposure. The long-term exposure to Hb-Hp results in the activation of the Nrf-2/ARE 
pathway and enhances the expression of anti-oxidative genes (HO-1, NQO1, ME1). 
Additionally, the by-products (CO, biliverdin, iron) of HO-1 activity have anti-oxidative 
properties and contribute to the cellular defense mechanisms. IL-8 expression is highly 
induced by Hb-Hp and serves as a chemoattractant for additional leukocytes. Further, Hb-Hp 
polarizes macrophages towards potent suppression of HLA class 2 molecules and the co-
stimulatory molecule CD86. Together, all mechanisms lead to cell and tissue protection 
during hemolysis. 
These results build a basis for further investigations on CD163 pseudo-receptors 
binding to Hb-Hp by means of SPR measurements in order to get more insights into 
CD163 conformation and function. Moreover, the herein indicated significant and 
consistent down-regulation of HLA class 2 receptors in human macrophages upon 
Hb-Hp exposure could stimulate research on shared intracellular trafficking and 
degradation pathways of Hb-Hp complexes and HLA class 2 molecules, respectively. 
Furthermore, this thesis revealed a putative link between Nrf-2 activation and IL-8 
secretion. Based on these findings, one could over-express and/or silence Nrf-2 
using lentiviral systems in order to monitor the impact on IL-8 expression following 
mutated Nrf-2 activity. 
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